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Q U IL L O N S C A L P E L

This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

PRESENT STATUS OF OTOLARYNGOLOGY
Those who are not well informed often con
sider otolaryngology as a specialty concerned
primarily with such mundane problems as
nose bleeds, tonsillectomies, sinus and ear
infections and the prescribing of antihista
mines for the treatment of postnasal dis
charge. While this type of work continues as
part of the general practice of the otolaryn
gologist there is no uniform definition today
as to what identifies an otolaryngologist or
what comprises the scope of his activities. As
the second oldest recognized surgical spe
cialty in North America, after ophthalmo
logy, otolaryngology serves as a good ex
ample of a discipline whose interests and
capabilities are overlapped by many other
specialties.
Otolaryngology is a medical and surgical
specialty that embraces otorhinolaryngology,
allergy, head and neck cancer surgery, plas
tic reconstructive and maxillofacial surgery
and bronchoesophagology. In order to prac
tise the specialty a physician must have ade
quate knowledge of the medical and surgical
problems related to the ear, nose, paranasal
sinuses, buccal cavity and appendages, pha
rynx, larynx, bronchi, neck, chest and eso
phagus, including the related nervous system.
The physician must have adequate knowl
edge of microbiology, biochemistry, em
bryology, pathology, pharmacology and
physyology as applied to the specialty.
A young physician who is qualified in
otolaryngology today has had at least 3
years of training in the specialty in addition
to 1 year in general surgery. Following this
many may subspecialize and take addi
tional training in an area in which they have
a particular interest, and limit their practice
to otology, rhinology, plastic and reconstruc
tive surgery, head and neck surgery, or some
0

other aspect of otolaryngology. These young
well-trained otolaryngologists might well be
regarded as “head and neck specialists”, and
there is a move currently gaining momentum
among these young people to make such a
change in designation.
The practice of otolaryngology for many
has become sophisticated and refined. The
use of the operating microscope has not only
completely upgraded surgical techniques in
the ear, particularly in reconstructive middle
ear and neuro-otologic surgery, but also in
the larynx, the nose and the paranasal si
nuses. We now appreciate the role of allergy
in rhinology and conservative surgery in
laryngeal carcinoma. In addition we have
contributed to improvements in reconstruc
tive surgery of the nasal pyramid. These are
but a few examples of the ever-changing
practice of otolaryngology.
Noise pollution has emerged as a major
problem in our society today. The applica
tion of government regulations to industry
has resulted in an ever-increasing demand
for expertise in this field. Many otolaryngo
logists are keenly interested and are deeply
involved in seeking solutions to various as
pects of the problem.
The relationship of otolaryngology to
overlapping specialties in the university mi
lieu can result in substantial patient benefit,
but in certain geographical areas this over
lapping has led to a conflict of interests.
This is understandable, for in order to excel
one must strive for perfection; such a goal
on the part of several people can lead to con
flicts. These conflicts can be resolved by
deciding on what is best for the patient; this
is the only basis for a solution.
While it is constructive to have a degree
of healthy competition between overlapping
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specialties it is also necessary to foster co
operation. As an example, audiology and
vestibular units, while properly under the
aegis of otolaryngology, are of great value
to other specialties such as ophthalmology,
neurology, neurosurgery and medicine.
In the nonuniversity milieu the relation
ship of otolaryngology to the other special
ties depends on the ability, availability and
progressiveness of the individual otolaryn
gologist. If an otolaryngologist is well trained

Vol. SO

and capable he will be recognized by the
physicians and surgeons in his community.
If he is available he will be sought after for
consultations. If he is progressive and keeps
up with the developments within his special
ty he will be a credit to otolaryngology.
J. D. Baxter,

md, frcs [c]

Professor and chairman,
Department of otolaryngology,
McGill University,
Montreal, PQ.

*

CARDIAC SURGERY: THE NEW CHALLENGE
Over the past 25 years there has been amaz
ing progress in the specialty of cardiac sur
gery. Although there had been earlier spora
dic efforts, it was experience gained in World
War II that led people to believe that surgery
on the heart was feasible. Gross, Crafoord
and Blalock proved that abnormalities rela
ted to the heart could be corrected or im
proved with extracardiac procedures, and
Harkins, Bailey and Murray demonstrated
the feasibility of closed-heart operations.
Bigelow showed us that the heart could, with
the use of hypothermia, be opened for short
periods of time. With the persevering efforts
of men such as Gibbons and Lillehei, openheart surgery became a reality.
Investigative procedures developed by
cardiologists, and improved anesthesia,
made it possible for a number of talented
surgeons to develop procedures for the cor
rection of cardiac abnormalities that could
now be identified in vivo. Coincident with
these many new developments was the
marked improvement in intensive care; car
diac surgery has become a way of life.
Initially, activities were directed to what
might be looked on as the gross problems re
lated to cardiac surgery. As these have been
solved, more attention has been devoted to
the finer details of improving prostheses and

learning about the physiology of individual
myocardial cells rather than the myocardium
as a whole. Coincident with this is the need
to assess the results: Is the mortality rate as
low as it can be? Does cardiac surgery pro
mote a better way of life? Has the life span
been prolonged and if so, is it rewarding?
What is the place of rehabilitation?
In many ways great progress has been
made, but much remains to be done. Most
congenital defects can be corrected, but can
they be prevented? Infections are being at
tacked; the ravages of rheumatic fever are
now preventable. Degenerative problems can
be greatly improved, but we have made little
progress in the understanding and prevention
of arteriosclerosis.
In this issue of the Journal (pages 101
to 146) the results of the work done by
some of our investigators are presented. We
commend them for their efforts; we urge
them to continue. We hope that their work
will encourage others to take up the chal
lenge of investigation.
Donald R. W ilson,
Professor and chairman,
Department of surgery,
University of Toronto,
Toronto, Ont.

md , frcs [c]
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SELF-ASSESSMENT
SESAP II QUESTION
350. A temporary or permanent cardiac pacem aker is LEAST likely to be required for a
patient who
(A) has Stokes-Adams attacks
(B) has congestive heart failure with complete heart block
(C) has atrial fibrillation and slow ventricular rate
(D) has sinus bradycardia with angina pectoris
(E) requires cholecystectomy and develops asymptomatic complete heart block
For this incomplete statement select the one completion that is best from the five given.
For the critique of Item 350 see page 177 of this issue.
(Reproduced by permission of the American College of Surgeons from SE SA P II Syllabus:
Surgical Education and Self-assessment Program No. 2.)

DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical resident submitting the
best paper on a surgical topic to the Canadian Journal of Surgery. This award is in
tended to promote scientific and literary excellence among Canadian surgeons in
training.
The conditions of entry for the 1977 award are the following: —
1. Candidates shall be currently engaged in a recognized surgical residency program
leading to eligibility for the Fellowship of the Royal College of Physicians and
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology,
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to
work in which a surgical resident is or has been the prime or major investigator.
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting
will not be a disqualification, but prior publication as a formal paper in a
journal will. The paper should relate to any field of surgical interest. The manu
script mustconform to the style requirements of the Journal and must not
exceed 3000 words of text and six tables and/or six figures. Coauthors are
permitted on the understanding that the candidate shall be the first author and
that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1977.
Each entry must be submitted to E. M. Cooperman, MD, FRCPfC], at the
office of the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont.
K1G 0G8, with a letter stating that the paper is being submitted as an entry
for the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of Surgery
unless returned to the author without publication.
All papers submitted will be judged by an independent committee comprising at
least one memberof the editorial board of the Journal, one fellow of the Royal College
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical
Association, together with other fellows invited to serve at the discretion of the three
permanent members of the committee. For the purpose of judging, the candidates will
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced
in the November 1977 issue of the Journal.
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LEFT ATRIAL THROMBOSIS COMPLICATING MITRAL STENOSIS:
RESULTS OF SURGICAL TREATMENT*
CONRAD PELLETIER, MD, FRCS[C],t SAAD BIZRI, MD, ROBERT COSSETTE, MD,
FRCS[C], LEON DONTIGNY, MD, FRCS[C] and ROLAND LEVY MD, FRCS[C]
In 343 patients treated surgically for mitral valve
disease, there was thrombosis of the left atrium
in 40. Massive atrial thrombosis was present in
32 of them, yet the diagnosis was suspected or
established preoperatively in only 12, because
of insufficient clinical signs. A transventricular
mitral commissurotomy was performed in 32 pa
tients and mitral valve replacement in the re
maining 8. Surgical mortality was 23% in the
patients with atrial thrombosis compared with
7% in the thrombus-free patients: 66% of the
deaths were due to cerebral embolism. Systemic
embolism occurred in 17% of the patients who
had a closed approach initially and in 27% fol- lowing a planned open procedure. Among the
survivors, 65% were asymptomatic or markedly
improved: the average follow-up was 42 months.
Atrial thrombosis increases the surgical risk
because of the high incidence of operative em
bolism, a complication that is not avoided by the
use of open procedures, but that could be pre
vented by earlier surgical treatment of mitral
stenosis, before atrial thrombi develop.
Parmi 343 patients operes pour une atteinte valvulaire mitrale, 40 avaient une thrombose de
I'oreillette gauche au moment de I'intervention.
Dans 32 des cas, il y avait une thrombose auriculaire massive, mais le diagnostic n’a pu etre
suspecte ou etabli avant I'operation que dans 12
a cause de I'insuffisance des signes cliniques.
Trente-deux patients ont subi une commissurotomie mitrale trans-ventriculaire et les huit autres
un remplacement valvulaire mitral. Chez les pa
tients ayant une thrombose auriculaire, la mortalite operatoire fut de 23%, comparativement a
7% en I'absence de caillots. L'embolie cerebrale
fut la cause des 66% des deces. Avec l'approche
chirurgicale initiate a coeur ferine, I'incidence
d'embolie systemique fut de 17%; elle fut de
27% chez les patients operes d'emblee a coeur

*From the division of cardiovascular and thora
cic surgery, department of surgery, Maisonneuve
and Sacre-Coeur Hospitals, University of Mont
real, Montreal, PQ.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct. 1823, 1976.
tScholar, Medical Research Council of Canada.
Reprint requests to: Dr. Conrad Pelletier, Cardio
vascular and thoracic surgery, Sacre-Coeur Hospi
tal, 5400 Blvd Gouin W. Montreal, PQ H4J lC5.

ouvert. Soixante-cinq pour-cent des survivants
restent asymptomatiques ou ameliores apres une
evolution post-operatoire moyenne de 42 mois.
La thrombose auriculaire augmente le risque
operatoire a cause de I’incidence elevee d'embolies, complication que n'elimine pas ('utilisa
tion d'une intervention a coeur ouvert, mais
qu'un traitement chirurgical precoce de la stenose mitrale pourrait aider a prevenir.
T hrom bosis of the left atrium remains a

major threat to patients with mitral valve
stenosis. This complication has been reported
in 5 to 26% of patients with mitral stenosis
treated surgically.1, 2 With the advent of
cardiopulmonary bypass, the incidence of
operative embolism in these patients has
been decreased but not eliminated.2 Knowl
edge of the presence of thrombi before sur
gery would greatly facilitate the manage
ment of this condition. Unfortunately, the
diagnosis is seldom made preoperatively, be
cause of the lack of typical signs. In addi
tion, there is no direct relationship between
preoperative systemic embolism and the
presence of left atrial clots at the time of
surgery.2- 4 This has been one of the argu
ments in support of the routine use of the
open approach to mitral stenosis.3 Since
closed mitral commissurotomy is still cur
rently used by our group, it was of interest
to analyze our results in regard to this prob
lem. In the present report, we have reviewed
our experience with 40 patients in whom
left atrial thrombi were found at surgery.
P a tien ts and M ethods

From Jan. 1, 1967 to Dec. 31, 1973,
343 patients with mitral valve disease
were treated surgically. Forty (12%) of
these patients were found to have thrombi in
the left atrium associated with mitral steno
sis. A closed mitral commissurotomy was
performed in 32 patients and mitral valve
replacement in the remaining 8. Table I
illustrates the respective incidence of atrial
thrombosis with each procedure. There were
26 women and 14 men. Among the patients
with atrial thrombi, 78% were older than 45
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TABLE I.—I ncidence of L eft Atrial T hrom
bosis in M itral Valve Surgery
No. of
cases
Procedures______________ (and % )

No. with left
atrial thrombosis
(and %)

Closed mitral
commissurotomy . 250 (73)
Mitral valve
replacement......... 93 (27)

8 ( 9)

Total......................... 343 (100)

40 (12)

32 (13)

years and the average age was 52 (range,
35 to 66 yr). Preoperatively, the functional
incapacity, based on the New York Heart
Association (NYHA) classification, was the
following: 1 patient in functional class II
(slight limitation of activity), 25 in class III
(marked limitation of activity) and 14 in
class IV (confined to bed or chair). Twentyfive patients had signs of, or had been treated
for, chronic heart failure and 10 patients
complained of typical anginal pain. Ten pa
tients had sustained systemic embolism prior
to their admission: cerebral vessels were in
volved in seven patients, renal vessels in
three and femoral arteries in two. Atrial fi
brillation was present in all patients, except
one, before operation. Four patients had
undergone a previous closed mitral commis
surotomy.
R o e n t g e n o g r a m s and C ardiac
C a t h e t e r iz a t io n

The left atrium was usually found to be
slightly to moderately enlarged on cardiac
roentgenograms. There was marked atrial
dilatation in only four patients. Slight calci

Vol. 20

fication of the mitral valve was seen in 21
patients, whereas there were densely calci
fied leaflets in only 6. Calcifications of the
left atrial walls were present in two patients
(Fig. 1).
The diagnosis of left atrial thrombosis was
established or suspected preoperatively in
only 12 patients. Left atrial angiography was
performed in six patients and was positive
in only three (Fig. 1).
Cardiac catheterization was carried out in
39 patients preoperatively. Most had a low
cardiac output with a cardiac index averag
ing 2.2 //m in m 2 in 36 patients (range, 1.0
to 3.5 //m in m 2). The pressure gradient
across the mitral valve averaged 18 mm Hg
at rest (28 patients); in 12 patients the
gradient was 20 mm Hg or greater. The mi
tral surface area was less than 1.0 cm2 in 19
patients, between 1.0 and 1.5 cm2 in 6 and
greater than 1.5 cm2 in 2. Pulmonary hyper
tension was present in 25 patients (63%),
with systolic pressures between 50 and 75
mm Hg in 20, and above 75 mm Hg in the
remaining 5. No significant degree of mitral
regurgitation was found in these patients.
There was an associated valvulopathy in
seven patients (aortic valve in six, tricuspid
valve in one).
O p e r a t iv e T e c h n iq u e s and F in d in g s

In 29 patients the operative approach was
through a left anterior thoracotomy (planned
closed procedure). In 14 of these patients, a
transventricular mitral commissurotomy was
done without cardiopulmonary bypass; the

Fig. 1.—Cineangiogram of patient with left atrial thrombosis. A : before injection, calcifications
are seen in wall of left atrium (arrows). B: large filling defect (arrows) in left atrium due to massive
thrombus.

TABLE I I — Surgical P rocedures in 40 P atients
with
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Left Atrial T hrombosis

Surgical procedures
Left atrial thrombectomy....................
Closed mitral commissurotomy.........
Mitral valve replacement....................
Associated procedures:
Aortic valve replacement................
Tricuspid valve replacement..........
Femoral embolectomy.....................
Pulmonary embolectomy................

No. of cases
39
32
8
1
1

atrial thrombi were either evacuated through
the atrial appendage incision (11 patients) at
the beginning of the procedure, or, when
firmly adherent to the appendage, excluded
at the end of the procedure (3 patients) by
ligation at the base of the appendage. In 15
patients, cardiopulmonary bypass was in
stituted through cannulation of the femoral
vessels following the discovery of atrial
thrombi on digital exploration. Fibrillation
was induced and the clots were removed;
subsequently a transventricular commissuro
tomy was performed after defibrillation.
Prosthetic replacement of the mitral valve
was carried out in two patients because of
severe regurgitation resulting from mitral di
latation.
In the remaining 11 patients a median
sternotomy was used and cardiopulmonary
bypass was instituted in the usual manner
before exploration of the left atrium (open
procedure). This approach was chosen either
because a valve replacement was contem
plated (seven patients), usually for heavily
calcified valves, or because a preoperative
diagnosis of left atrial thrombosis had been
made (four patients). Following fibrillation,
the left atrium was opened and the thrombi
extruded. In one case a completely endothelialized mural thrombus was firmly adherent
to the posterior wall and could not be re

moved. Table II details the various surgical
procedures performed in this study.
In 32 patients massive thrombosis of the
left atrial cavity was found. The thrombi
were predominantly adherent to the poste
rior wall with a varying degree of pulmonary
vein obstruction. In eight patients, throm
bosis was limited to the atrial appendage.
Severe mitral stenosis was found in all but
one patient with massive thrombosis of the
left atrium and minimal valve stenosis.
R esults

Surgical Mortality and Complications
The respective surgical mortality in pa
tients with and without thrombosis of the
left atrium is shown in Table III. In the 40
patients with atrial thrombi, there were 9
operative deaths (23%) compared with an
operative mortality of 7% in the thrombusfree group. Three of the nine deaths were
not related to the presence of atrial throm
bi. Two patients died of acute left ventricular
failure at the termination of cardiopulmo
nary bypass; in both, technical difficulties
followed mitral valve replacement. One pa
tient, who sustained massive pulmonary em
bolism preoperatively, died during operation.
Six patients died 1 to 30 days after surgery
from cerebral embolism (Table IV). Severe
neurologic deficits were present before oper
ation in three of these patients owing to re
cent cerebral emboli: in one there were signs
of a new embolic episode immediately fol
lowing operation, while in the other two pre
existing deficits extended. In the remaining
three patients, cerebral embolism occurred
during operation, and two of these patients
also had coronary and femoral emboli.
In two other patients neurologic deficits at-

TABLE III.— I nfluence of Left Atrial T hrombosis on S urgical M ortality in

M itral Valve Surgery
Total no. o f
cases

Procedures
..........
...............
..............

40

Patients without left atrial throm bosis:............................ .....................
Mitral commissurotomy................................................... .....................
Mitral valve replacement.................................................. .....................

303

Patients with left atrial thrombosis: ..................................
Mitral valve replacement..................................................

*Including patients with multiple surgical procedures.

Surgical mortality
\and% )
9 (23)
5(16)
4 (50)

32
8*
22 ( 7)
218
85*

9 ( 4)
13 (15)

104

TH E C A N A D IA N JO U R N A L OF SU R G E R Y

Vol. 20

T A B L E I V — Surgical C omplications and C auses of D eath in P atients with

Left Atrial T hrombosis

Complications_____
Cerebral em bolism ...............................................................
Closed approach.................................................................
Open approach...................................................................
Acute heart failure.................................................................
Pulmonary embolism.............................................................

Surgical deaths

Survivors

0*

2
2

3
3
2
1

Total
8
5
3

q

0
0

2
1

*Two patients had associated emboli (coronary, femoral).

tributed to cerebral embolism developed
after operation; subsequently the deficits re
solved (Table IV). In all, 8 patients suffered
systemic embolism that could be related to
surgery — 5 (17% ) of the 29 patients who
underwent a planned closed procedure
and 3 (27% ) among the 11 patients who
underwent an open procedure. Massive
atrial thrombosis was present in all but one
patient who survived following a cerebrovas
cular accident; in this patient a small throm
bus in the atrial appendage had been evacu
ated through the atriotomy before dilation
of the mitral valve.

with resection of ventricular aneurysm and
aortic commissurotomy.
Anticoagulants were not administered
routinely after operation. In 15 patients, in
cluding 5 with a valvular prosthesis, long
term anticoagulation therapy was prescribed.
One patient suffered a myocardial infarc
tion 2 weeks after operation; this was at
tributed to coronary embolism. He subse
quently received anticoagulants. There were
no other instances of systemic embolism
during follow-up. Two patients receiving
anticoagulants suffered a cerebral hemor
rhage 5 and 20 months after operation, re
spectively; one made a full recovery and the

Late Follow -U p Data

Follow-up of the 31 survivors ranged
from 6 to 103 months (average, 42 mo) (Ta
ble V). Twenty patients (65%), including 16
who underwent commissurotomy and 4 who
had valve replacement, remained asympto
matic or were markedly improved (NYHA
classes I and II). Eight patients remained un
changed or deteriorated progressively follow
ing initial mitral commissurotomy (Fig. 2);
seven of them (26% of those who survived
the initial commissurotomy) were advised
to undergo mitral valve replacement —
six complied, 12 to 94 months (average, 41
mo) after initial surgery. No atrial thrombi
were found at reoperation in these patients.
Three patients had the following associated
procedures: aortic valve replacement, aorto
coronary bypass, and aortocoronary bypass
T A B L E V.— L ong-T erm F ollow-Up D ata of 31

P atients S urviving I nitial Surgery

Follow-up
Total cases...........................................
Asymptomatic or improved...............
Reoperation needed (valve
replacement)...................................
Late death............................................
Late systemic embolism.....................
Long-term anticoagulation................

No. of patients
31
20
7
4
1
15

*

RE OP

Fig. 2.-N ew York Heart Association (NYHA)
functional classification in 31 patients who sur
vived initial surgical procedure; preoperative and
last visit or at reoperation. (CMC = closed mitral
commissurotomy, MVR = mitral valve replace
ment.) *Six patients underwent reoperation (REOP)
for mitral valve replacement during follow-up.

March 1977

THE CANADIAN JOURNAL OF SURGERY

other died. There were three additional late
deaths — one 7 months after operation from
respiratory insufficiency, and the others 18
and 94 months after operation from heart
failure (total late mortality, 13%). One of
these patients died of congestive heart fail
ure following reoperation for mitral valve
replacement and aortocoronary bypass.
D iscussion

Left atrial thrombosis was present in 12%
of our patients operated upon for mitral
valve disease. Most had massive thrombosis,
yet the diagnosis was seldom made preoperatively (30%). The difficulty of establishing
such a diagnosis before surgery is well recog
nized.^- (i The various factors usually asso
ciated with atrial thrombosis have been re
viewed by Ullal and colleagues.1' However,
none of these is diagnostic. In our group of
patients, most were older than 45 years and
had a clinical history of chronic congestive
heart failure; in addition, all but one were in
a state of atrial fibrillation. The radiographic
size of the left atrium and the degree of val
vular calcification bore no relationship to
atrial thrombosis; calcified atrial walls were
an exceptional finding. In most instances the
patients had severe mitral stenosis. Like
others,fi we found an unusually high inci
dence of angina, suggesting associated
ischemic disease of the myocardium. How
ever, in this series coronary artery angio
graphy was not done and other factors, such
as low cardiac output, pulmonary hyperten
sion and coronary embolism, could have con
tributed to the angina. Systemic embolism
before surgery, though not uncommon, is not
invariably associated with the finding of
atrial clot at operation.2- 4 Only 10 of our
patients had a previous history of embolism.
The surgical mortality was substantially
higher when left atrial thrombosis was pre
sent than when it was not (23% v. 7% ).
Two thirds of the patients died from syste
mic embolism, and 50% of them had severe
neurologic deficits before operation. It has
been claimed that the incidence of embolism
could be reduced consistently by routine use
of open mitral commissurotomy.3 Postoper
ative embolic complications of 2 to 8% and
operative mortality of 2% or less were re
ported with this procedure.2
However,

105

such results have not been obtained uni
formly. An operative mortality of 25 and
30% and an incidence of postoperative em
bolism of 10 and 12% were reported by Ullal
and colleagues6 and by Peterson and asso
ciates,7 respectively, in patients who had
either a mitral valve replacement or an open
commissurotomy. These figures are similar
to our results. Systemic embolism directly
related to surgery occurred in six (15% ) of
our patients; four patients (10% ) died of a
cerebral embolism suffered during operation
while in two others (5% ) a prior stroke was
extended. Among our patients, the incidence
of embolic accidents was higher (27% ) in
the patients who underwent an open proce
dure than in those for whom a closed proce
dure was initially chosen (17% ). Therefore
it is uncertain that the systematic use of open
procedures would contribute substantially to
the prevention of this major complication.
On the other hand, only eight of our patients
required valve replacement. In six of them,
prosthetic replacement was planned because
of heavily calcified valvular leaflets. In only
two patients was the mitral valve replaced
after a closed commissurotomy had failed.
From published reports, it is often difficult
to recognize the relative incidence of valve
replacement required because of the failure
of an open commissurotomy. In the group
of patients reported by Roe and colleagues,2
44% had a valve replacement. Finnegan and
colleagues8 noted a more than twofold in
crease in valve replacement after they aban
doned closed mitral commissurotomy. With
otherss- 11 we believe that when commissuro
tomy is performed in the closed beating
heart there is a lower incidence of secondary
regurgitation and of valvular replacement.
The long-term results of this study have
also been satisfactory; 65% of the survivors
were restored to functional NYHA classes
I or II for an average follow-up period of
3 Vi years. Within the same period of time,
7 (26% ) of the patients who initially had a
closed commissurotomy required reopera
tion. This compares favourably with the re
sults of Ellis and associates8 in a long-term
follow-up study of 1000 cases of closed com
missurotomy. As pointed out by Hanlon and
associates,1" even though the open approach
to mitral commissurotomy may offer certain
theoretical advantages, the long-term results
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have not yet established the superiority of
this technique.
A high incidence of late recurrent em
bolism or atrial thrombosis has been re
ported.6- 7 This has not been our experience
even though anticoagulant therapy was not
used routinely after operation. Only one pa
tient had a possible late embolic episode and
no atrial thrombi were found in the six pa
tients who underwent reoperation. Our cur
rent policy is to prescribe anticoagulants for
all patients with a valvular prosthesis and
when rough endocardial surface remains
after excision of a large atrial thrombosis.
When thrombi are present in the left atrial
cavity, cardiopulmonary bypass is manda
tory in order to achieve complete excision.
We now use the approach of Gott and his
colleagues!> in patients who are at high risk
for such a complication. A sternal-splitting
incision is made and the patient placed on
partial cardiopulmonary bypass. With the
heart beating, a digital exploration is per
formed and a transventricular closed com
missurotomy is done if the atrium is free of
clot. When thrombi are present the atrium
is opened to evacuate the thrombi, and a
transventricular commissurotomy performed
after atrial closure and defibrillation.
This technique offers both the advantages
of closed commissurotomy and the security
of readily available total bypass in case
thrombi are found. In patients with low risk
of atrial thrombosis, we perform closed com
missurotomy through a left anterior thoraco
tomy. To improve preoperative disclosure of
atrial thrombosis, left atrial cineangiograms
are used more frequently, and we are now
assessing the value of echocardiography in
the diagnosis of this condition. Whatever the
surgical technique used, atrial thrombosis
remains a major and potentially lethal com
plication of mitral stenosis, and efforts
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should be directed towards its prevention.
This goal could be achieved by earlier sur
gical treatment of patients with proven mi
tral stenosis; because only a small risk is
involved with closed commissurotomy the
surgeon may adopt a more aggressive atti
tude towards the minimally disabled patient.
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EFFECT OF UNILATERAL PULMONARY ARTERY OCCLUSION ON
THE ARTERIAL OXYGEN PRESSURE OF CHILDREN UNDERGOING
PULMONARY SYSTEMIC ARTERY SHUNT PROCEDURES*
D. A. MURPHY, MD, G. L. D U N N , M D, D. A. GILL1S, MD, A. R. C. DOBELL, MD
and A. S. W ENN IN G , MD
Of 20 children undergoing thoracotomy who had
blood-gas analysis at various intervals during
their operative procedure, 18 had congenital
heart disease causing cyanosis. The venous ad
mixture was apparent on compressing the lung
to expose the mediastinal structures and was di
minished upon clamping the pulmonary artery to
the exposed lung. This observation may be of
clinical value in raising the arterial oxygen pres
sure when sudden deterioration occurs during
performance of a systemic pulmonary shunt in
cyanotic children.
Parmi 20 enfants qui ont subit une thoracotomie
et chez qui on realisa des analyses des gaz sanguins a divers intervalles durant leur intervention
chirurgicale, 18 souffraient d’anomalies cardiaques congenitales causant de la cyanose. Le me
lange veineux etait apparent apres compression
du poumon de fagon a exposer les structures
mediastinales et il etait diminue par clampage
de I'artere pulmonaire menant au poumon expo
se. Cette observation peut avoir un interet Clini
que lorsqu'il faut augmenter la pression arterielle d’oxygene, en presence d'une deterioration
subite pendant la realisation d'une derivation
pulmonaire generale chez les enfants cyanotiques.

I n the creation of a systemic to pulmonary
artery shunt, it is necessary temporarily to
occlude one of the pulmonary arteries. Cya
notic children, even with low arterial oxygen
pressure (Pao2), usually tolerate this proce
dure well. Since a portion of one lung is com
pressed during the surgical procedure, we
considered it possible that occlusion of the
pulmonary artery to the collapsed segment
*From the departments of surgery and anesthe
siology, Dalhousie University, Halifax, NS and
McGill University, Montreal, PQ.
Supported by the Nova Scotia Heart Founda
tion and the Quebec Heart Fund.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct.
18-23, 1976
Reprint requests to: Dr. D. A. Murphy, Director,
Division of cardiovascular surgery, Dalhousie
University, 5850 University Ave., Halifax, NS
B3J 3G6.

by decreasing the venous admixture, would
result in an increase in Pao2. To test this
hypothesis, arterial blood gases were meas
ured in 20 children at various stages during
the surgical procedure.
M a t e r ia l s a n d M e t h o d s

Over a period of 4 years, 18 children with
congenital heart disease causing cyanosis
and 2 children with atrial septal defects at
the Izaak Walton Killam Hospital for Chil
dren and the Montreal Children’s Hospital,
underwent arterial blood-gas analysis se
quentially during their operative procedure.
The two patients with atrial septal defects
underwent closure of these defects through
a right thoracotomy, and the pulmonary
artery was temporarily occluded during the
preliminary steps before initiating cardiopul
monary bypass. The cyanotic children all un
derwent systemic to pulmonary artery shunts.
Not all children undergoing shunts at these
centres were included in the study since
emergency situations, tiny infants and surg
ical or hemodynamic changes during the
operative procedure precluded complete stu
dies and prevented their inclusion in the
series.
Duplicate blood samples were taken with
heparinized plastic syringes from Teflon
needles inserted percutaneously or through
exposed radial, temporal or posterior tibial
arteries. The syringe plunger was rinsed with
full-strength heparin and the excess dis
charged from the syringe, except for the
small amount left in the nozzle tip. Before
the duplicate sample was taken, 1 ml of
blood was withdrawn from the arterial line
and discarded. Air was expressed from the
syringe, which was corked and placed on
ice; blood gases were measured within 30
minutes on a Radiometer M ark 2 physio
logical blood gas analyzer (Radiometer Co.,
Copenhagen).
Anesthetic techniques and doses of anes
thetic agents used varied with the anesthetist
and the particular case. However, in all
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cases, anesthesia was maintained with D-tubocurarine and either morphine or keta
mine, and the patients were ventilated with
100% oxygen throughout the procedure.
In patients weighing less than 20 kg, ven
tilation was achieved with a Bird Mark VII
respirator coupled to the patient via a Bird
Mark IV patient assister, which was attached
to the expiratory limb of a standard Rees Tpiece. The accurate measurement of tidal
and minute volumes is extremely difficult in
small infants and neonates so ventilation was
initiated at a fixed rate of 20/min and the
tidal volume was set empirically.
The following lists the blood sampling se
quence :
1. Patient supine after induction on inter
mittent positive pressure ventilation
2. Patient in anterolateral thoracotomy
position:
A—chest open but lung not retracted
B— lung compressed longer than 5 min
C— pulmonary artery occluded, 1 min
D— pulmonary artery occluded, 5 min
E— pulmonary artery released, 5 min
F— pulmonary artery released, 30 min
G— pulmonary artery clamped for shunt,
1 min
H— pulmonary artery clamped for shunt,
5 min.
At no time was the normal sequence of
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surgery, or the patient’s safety jeopardized.
The pulmonary artery occlusion was carried
out as the systemic vessel was being pre
pared (steps C to F), and the remaining steps
occurred during the anastomosis.
R e su lt s

The average, duplicate, sample values for
all patients are listed in Table I. In order to
compare patients, the percentage changes in
Pao2 between each maneuver were calcu
lated; the differences are summarized in Ta
ble II.
The Pao2 decreased 17% (P < 0.01) when
the lung was collapsed to expose the me
diastinal structure (A to B). The pulmonary
artery was dissected from its bed, encircled
and subsequently occluded. This maneuver
resulted in a 7% increase in Pao2 at 1 min
ute (P < 0.025) and a 9% increase by 5
minutes (P < 0.025). However, upon release
of the pulmonary artery for 5 to 30 minutes
there was no substantial change in the Pao2
from the 9% increase (B to E or B to F).
Although further clamping of the pulmonary
artery to complete the anastomosis resulted
in a 2 to 3% increase over the original pre
clamping value (B to C, B to H), there was
actually a 9 to 7% decrease in Pao2 com
pared with the values just prior to reclamping
the pulmonary artery.

TABLE I.—A verage Arterial Oxygen P ressure of D uplicate Samples T aken D uring Study
20 C hildren with C ongenital H eart D isease C ausing C yanosis

of

Samples
Heart defects
Tetralogy....................................
ASD.............................................
T A ...............................................
A SD ..............................................
Tetralogy......................................
TGA, P A ......................................
Tetralogy......................................
DC. SV, P S .................................
PS, VSD, TG A ...........................
Atrioventricular canal, PS........
TGA, PS, D C .............................
T A .................................................
PA, VSD......................................
Tetralogy......................................
T A .................................................
PA................................................
Tetralogy.....................................
PA................................................
TGA, TA, P A B ..........................
Tetralogy.....................................

A
55
452.5
39
560
54
17
84
52
45
63
73
50
80
425
48
71
69
63
—
52

B
42.5
370
31
445
37.5
22
42
53.5
40.5
39.5
70
48.5
39
223
50
73
61.2
57
62
42.5

C
47.5
165
26
427.5
47
25
55.5
58.5
42.5
38.5
67.5
68
48.5
335
54
77.5
67
53
60
42

D
47
182.5
32
420
51
21.5
58
60.5
41.5
45.5
66
67
52
326.5
55.5
68
65.5
56
56.5
44

E
53
357.5
27
—
50
21.5
58
56
40
40
65
66
49.5
280
—
69.5
69
63
61
43

F
_
—
30
420
—
—
61
—
43
43
—
66
52.5
234
—
42.5
—
60

G
_
—

_
—
—

—
54
52.5
42
41
—
49
40.5
250.5
—
42
68
46
63.5
52.5

H

_
_
_
_
50
_
53.5
41
41.5

57.5
45
287.5
52
39
71
39
53
51.5
47
ASD = atrial septal defect; TA = tricuspid atresia; TGA = transposition of the great arteries; PA =
pulmonary atresia; DC = dextrocardia; SV = single ventricle; PS = pulmonary stenosis; VSD = ventri
cular septal defect; PAB = pulmonary artery banding.
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In other words, initially there was a small
(7 to 9% ), but significant (P < 0.025), in
crease in Pao2 upon clamping the pulmon
ary artery. The Pao2 did not return to its
previous preclamping level when the pul
monary flow was supposedly re-established.
After approximately 30 minutes, the syste
mic artery was dissected free and the formal
anastomosis begun. It then was necessary
to clamp the pulmonary artery again; this
resulted in a surprising decrease (9 to 7% ,
P < 0.025, 0.05) in the measured Pao2.
D iscussion

The Pao2 decreased by an average of
17% (P < 0.01) when the chest was opened
and a portion of one lung was collapsed to
expose the relevant hilar structures. This is
in keeping with experimental1 and clinical
studies2"4 demonstrating venous admixture
to the left side of the heart with lung col
lapsed.
The small, but significant, increase in the
systemic Pao2 observed on clamping the
pulmonary artery to the partially collapsed
lung is not a new observation;5 however, it

is important that it occurs in cyanotic chil
dren with major intracardiac shunting. This
observation can be put to clinical advantage
when a child deteriorates during the perform
ance of such a shunt. Most surgeons favour
an open pulmonary artery until the last mo
ment; they consider that some ventilation is
better than none in patients with such a cri
tically low Pao2. We did not study children
with an unoccluded pulmonary artery whose
exposed lung continued to be partially ven
tilated; it is therefore not known whether
the Pao2 would also increase 7 to 9% with
out pulmonary artery clamping. It is unlike
ly that this would occur, since most clinical
observations in adults indicate a decrease in
the Pao2 in this situation.
It is surprising that upon releasing the pul
monary artery after the first clamping, the
Pao2 did not decrease to its preclamping
value. If the collapsed lung continued to
supply venous blood to the left atrium after
re-establishing blood flow to the lung, a de
crease in Pao2 would be expected. In ex
perimental acute atelectasis in the open
chested animal, there is an initial decrease
in pulmonary vascular resistance.1- 6> 7 An

TABLE II.— Summary of P ercentage D ifferences in Pao2 ( mm H g )
Mean ( ± )

Standard
deviation (a)

A Chest open but lung not retracted.................. ............
B Lung compressed > 5 m in ..............................

- 0.17

0.21

B
C PA occluded 1 min............................................ ............

+ 0.07

0.22

< 0.025

B
D PA occluded 5 m in............................................. ............

+ 0.09

0.22

< 0.025

B
E PA released 5 min.............................................. ............

- 0.10

0.16

< 0.01

B
F PA released 30 min............................................ ............

+ 0.10

0.24

< 0.025

B
G PA clamped 1 min. Shunt................................. ............

0.02

0.19

< 0.05

B
H PA clamped 5 min. Shunt................................. ............

+ 0.03

0.23

< 0.05

E PA released 5 min.............................................. ............
F PA released 30 min............................................

- 0.01

± 0.13

< 0.05

E
G PA clamped 1 min. Shunt................................ ............

- 0.09

0.17

< 0.025

E
H PA clamped 5 min.............................................. ............

- 0.07

0.18

< 0.05

Sampling sequence

PA = pulmonary artery.

Significance
(P)
< 0.01
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increase in pulmonary flow is followed quick
ly by a progressive increase in vascular re
sistance and approximately 15% reduction
in pulmonary flow. In the intact animal, the
shunt flow decreased by approximately 30%
in 3 hours of collapse A In chronic atelecta
sis, a marked reduction in blood flow occurs;
this has been attributed to the organic
changes in the lung rather than to the reflex
vasoconstriction observed in acute atelecta
sis. Organic changes can occur as early as 6
hours,9 but were not observed at all by Hinshaw and Emerson1" in an earlier, but simi
lar, study. It is possible that after release of
the pulmonary artery following the initial
occlusion, the blood flow to the atelectatic
segment is not restored because, in spite of
an open pulmonary artery, these reflexes
persist. This theory could be studied by
measuring flows with an electromagnetic
flow probe to the relevant lobe before and
after pulmonary artery occlusion.
Approximately 30 minutes elapsed be
tween the initial pulmonary artery occlu
sion and the beginning of the formal shunt
procedure. During this time, ventilation had
not been adjusted. When the clamps were
reapplied, a significant decrease in Pao2
occurred. Several explanations for this are
possible. Changes in cardiac output or in in
tracardiac shunting could occur. These could
alter the mixed venous Pao2 and clearly in
fluence the measured Pao2. To study this
one would have simultaneously to measure
the mixed venous Pao2 with the arterial
Pao2 to ensure that no changes in arterio
venous oxygen difference were occurring. It
is possible that a change in arteriovenous
oxygen could occur as an isolated event, but
it is unlikely that such a change would be a
consistent finding since each patient in our
study had a variable intracardiac anatomy.
A more likely explanation is that in the in
terval of 30 minutes to 1 hour of fixed-vol
ume respiration, patchy atelectasis occurred
in the dependent lung. This would have
brought about a notable decrease in the
Pao2 if the pulmonary artery to the sur
gically exposed lung was occluded.11' 14
This certainly was apparent in the first atrial
septal defect study (Table I), in which a
marked decrease in Pao2 occurred when the
pulmonary artery to the partially collapsed
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lung was occluded; the pressure immediately
increased when pulmonary flow to the ex
posed lung was re-established.
We thank the many uncomplaining technicians
at the Izaak Walton Killam Hospital for Children
and the Montreal Children’s Hospital laboratories
who performed the blood-gas studies. We also
recognize the cooperation of many anesthetists
involved in the study, particularly Drs. E. Rhyne,
J. Rosales, C. Townsend, A. Scott and J. Morri
son. Dr. A. Marble’s assistance with the statis
tical analysis was most appreciated.
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PREDICTIVE VALUE OF MYOCARDIAL PERFUSION IMAGING
FOR AORTOCORONARY BYPASS SURGERY*
WILLIAM J. KOSTUK, MD, FRCPfC] and MICHAEL J. CHAMBERLAIN, MD, FRCP[C]
Evaluation of patients for aortocoronary bypass
(A C B ) surgery is dependent on the findings at
cardiac catheterization. Left ventricular angio
graphy cannot distinguish between reversible
and irreversible myocardial dysfunction. In 82
patients macroaggregates of human serum al
bumin, labelled with iodine-131, were injected
before operation into the right coronary artery
and technetium-99m labelled microspheres were
injected into the left coronary artery. Two weeks
after operation similar technetium-99m and
iodine-131 injections were made into the native
vessels and grafted vessels, respectively. Myo
cardial distribution of the 20 pi. particles was
visualized with a rectilinear scanner. Sixty-seven
patients had normal myocardial perfusion scans
preoperatively even though wall motion was ab
normal in 34. There was substantial improvement
in the left ventricular function of these 34 pa
tients; the mean ejection fraction increased from
56 to 6 5 % . Fifteen patients had abnormal myo
cardial perfusion scans; improvement in left
ventricular function in this group occurred only
if the bypass graft was made to an area with
normal regional perfusion preoperatively. It is
certain that an adequate capillary bed is present
if the myocardial scan is normal, regardless of
the degree of critical stenosis in either coronary
artery. The patient with a completely occluded
coronary artery and normal myocardial scan is a
good candidate for ACB and will show improved
left ventricular contraction if the A CB is patent.
L’evaluation d'un patient en prevision d'un pon
tage aortocoronarien (P A C ) depend des resultats
du catheterisme cardiaque. L’angiographie du
ventricule gauche ne peut distinguer entre une
insuffisance myocardiaque reversible et une insuffisance irreversible. Chez 82 patients, des
macro-aggregats de serum albumine humaine
marquee a l'iode-131 ont ete injectes, avant I'operation, dans I'artere coronaire droite, et des mi
crospheres marquees au technetium-99m ont ete
injectees dans I'artere coronaire qauche. Deux
semaines apres I'intervention des injections si
milaires de technetium-99m et d'iode-131 ont ete
faites, respectivement dans les vaisseaux natu-

*From the cardiac investigation unit, University
Hospital, London, Ont.
Supported by the Ontario Heart Foundation.
Presented at annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct.
18-23, 1976.
Reprint requests to: Dr. William J. Kostuk, Car
diac investigation unit, University Hospital, 339
Windermere Rd., London, Ont. N6A 5A5.

rels et dans les vaisseaux greffes. La distribu
tion myocardiaque des particules de 20 u a ete
mise en evidence a I'aide d'un scintigraphe rectiligne. Soixante sept patients ont presente des
scintigraphies de perfusion myocardiaque normales avant I'operation, bien que le mouvement
de la paroi ait ete anormal chez 34 d'entre-eux.
II y a eu une amelioration sensible du fonctionnement du ventricule gauche chez ces 34 patients;
la fraction moyenne dejection a augmente de 56
a 6 5 % . Quinze patients avaient une scintigraphie
de perfusion myocardiaque anormale; dans ce
groupe ('amelioration de la fonction ventricu
laire gauche n’est survenue que lorsque le pon
tage a ete fait vers une region qui etait normalement perfusee avant I'operation. II est certain
qu'un lit capillaire adequat est present, lorsque
la scintigraphie du myocarde est normale, quelque soit le degre de stenose critique de chacune des arteres coronaires. Le patient ayant
une artere coronaire completement obliteree
mais presentant une scintigraphie du myocarde
normale, devient alors un bon candidat au PAC
et il beneficiera d'une amelioration de la contrac
tility du ventricule gauche si le PAC est fonctionnel.

A ortocoronary bypass (ACB) surgery is
being performed with increasing frequency
to relieve symptoms of coronary atheroscle
rosis.11’ Preoperative evaluation is depen
dent not only on the coronary anatomy, as
defined by selective coronary angiography,
but also on left ventricular contraction as
seen during left ventriculography. Unfor
tunately, the ventricular angiogram does not
differentiate contraction abnormalities due
to ischemia and those due to scarring.
Such differentiation is essential if aortocoro
nary bypass surgery is contemplated: :!‘,i
delivery of additional blood to a region of
ischemia should be of benefit, whereas in
creased blood flow to scarred myocardium is
of no value and is a risk to the patient.
Evaluation of regional myocardial perfu
sion with labelled macroaggregated albumin
(MAA) particles is a promising technique
that can differentiate abnormalities due to
ischemia and to scarring.7 111 During the
past 3 years, we have evaluated this method
in patients undergoing diagnostic coronary
angiography.101 - The present report deals
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with our experience in 82 patients who un
derwent ACB. These patients were studied
before and after operation.
The purpose of the study was to answer
the following question: with labelled MAA
myocardial perfusion imaging, is it possible
to predict preoperatively which patients with
an abnormality of left ventricular contrac
tion will show improvement in left ventri
cular function after successful ACB?
P a t ie n t s a n d M e t h o d s

The study comprised 82 patients with
chronic stable angina pectoris. Selective co
ronary angiography and left ventriculography
were performed (with the patient’s consent)
with the patient at rest; little or no premed
ication was used. Timed power injections of
40 to 45 ml of Renografin 76 (meglumine
diatrizoate and sodium diatrizoate) were
used for chamber angiography, and manual
injections of 6 to 10 ml of contrast medium
were used for selective coronary arterio
graphy. All angiography was recorded on 35mm cine film at 60 frames/s. Postoperative
evaluation carried out a median of 14 days
after operation (range, 10 d to 3 mo), con
sisted of left ventricular angiography and
selective injection of the bypass grafts and
coronary arteries.
Following selective angiography, labelled
particles of human serum MAA were in
jected into each of the coronary arteries and
each of the ACB grafts. In the preoperative
study, particles of MAA labelled with iodine131 (131I) were injected into the right coro
nary artery, while particles labelled with
technetium-99m (i,n”Tc) were placed into
the left coronary artery. In the postoperative
study, the " mTc-labelled MAA was injected
into the native vessels and the 131I-labelled
MAA into the bypass grafts. The particles
are 20 to 30 ^ in diameter and have a bio
logic half-life of 3 to 5 hours. The dose
range for 0:'mTc was 200 to 300 pCi con
sisting of 20 000 to 30 000 particles; 100
/aCi of 131I was used with a similar number
of particles.
Following completion of the invasive car
diac procedure, the patients were transferred
to the department of nuclear medicine for
myocardial imaging. Myocardial scans were
obtained in both a 45° left anterior oblique
and an anterior view with a rectilinear scan

ner. The scanner is connected to a computer
that permits a colour-coded pictorial display
and allows differentiation of radioactivity
in the appropriate count range. Use of the
dual isotope technique is particularly help
ful because separate preoperative evaluation
of both right and left coronary artery perfu
sion can be obtained. In addition this tech
nique allows differentiation postoperatively
of perfusion through the native arteries and
through the ACB grafts.
Left ventricular volumes and the ejection
fraction (EF) were calculated from enddiastolic and end-systolic silhouettes in the
right anterior oblique projection and the
single-plane area length m ethod.13 Each
ventriculogram was analyzed by Herman’s
method14 for the presence of regional ab
normalities of wall motion. All premature
contractions and immediately successive
beats were excluded from analysis. The
myocardial perfusion images were read with
out knowledge of the laboratory data. The
normal image was defined as the uniform
perfusion of the arterial bed injected. The
abnormal image was a clearly discernible
region of diminished or absent activity. Tech
nically unsuitable images were excluded.
R esults

Of the 82 patients in this study, 67 had
an overall normal myocardial perfusion scan,

LEFT

VENTRICULAR

CO N TR ACTIO N

Fig. 1.—Patient population with normal myocar
dial scintiscans grouped into preoperative normal
or abnormal left ventricular contraction. Height
of bar represents mean ejection fraction (EF) ±
standard error of mean. Number in clear bar in
dicates number of patients in each group. N S =
not significant.
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while in 15 patients perfusion defects were
present and the labelled albumin-particle
scan was abnormal.
Patients with normal myocardial perfu
sion scans can be divided into two groups
based on the left ventricular contraction —
normal left ventricular contraction (group
1) and abnormalities of wall motion in the
form of hypokinesis, akinesis or dyskinesis
(group 2) (Fig. 1). The 33 patients in group
1 showed no change in EF after operation;
the value remained at 75% . Preoperatively
the 34 patients in group 2 had a mean EF of
56%. Postoperatively, there was a substan
tial improvement in left ventricular contrac
tion; the mean EF increased to 65% (Figs.
2 and 3).
The results of EF in the 15 patients in
whom there was a perfusion defect on the
myocardial scan are shown in Fig. 4. The
patient groups indicate whether the regional
myocardial perfusion to which a bypass graft
was inserted was normal or abnormal. In
the eight patients who had a normal region
al perfusion, preoperative EF was 52% ; this
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increased to 58% after operation. Although
the trend was towards improvement, it was
not statistically significant. In the seven pa
tients who had a bypass graft to a region
associated with a perfusion defect, there was
no change in the left ventricular EF; the
mean value remained at 45% . Figs. 5 to 7
illustrate the findings in a patient in whom
a bypass graft had not altered the myocardial
perfusion. Indeed, the operation was asso
ciated with a deterioration of left ventricular
function.
The overall postoperative change in left
ventricular function in the patients who had
abnormal left ventricular contraction pre
operatively is shown in Fig. 8. Of the pa
tients who had normal myocardial perfusion
scans in spite of abnormalities of left ventri
cular contraction, 62% showed an improve
ment in left ventricular function; 29% re
mained unchanged, while only 9% showed a
deterioration. On the other hand, of patients
in whom there was a perfusion defect, only
33% showed an improvement and 27% ex
hibited a deterioration.

<
< —<
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y

v

Fig. 2.—Normal preoperative myocardial perfusion scan with labelled macroaggregated albumin
(M A A ). Regional myocardial perfusion supplied by right coronary artery (A) and left coronary artery
(B) of patient with abnormal left ventricular contraction in form of inferior-wall akinesis (EF, 59%).
Right coronary artery perfusion is abnormal owing to proximal occlusion of this vessel; however, left
coronary artery supplies inferior wall through collateral vessels. Combined view of A and B is shown
in C. In this and all subsequent scans, left anterior oblique view is at top and anterior view at bottom.
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Fig. 3.—Postoperative myocardial perfusion scan of patient in Fig. 2. A is perfusion of right and
left coronary artery showing large perfusion defect in inferior wall and area of ventricular septum. B is
perfusion supplied by aortocoronary bypass (ACB) grafts to right, left anterior descending and left cir
cumflex coronary arteries. C represents combined overall normal perfusion through coronary arteries
and ACB grafts. Left ventricular contraction returned to normal (EF, 69%).
D iscussion

EJE C TIO N

F R A C TIO N

There are many reports in the literature
dealing with the selection of patients for
ACB surgery. Most investigators agree that
the critical factors in predicting a success
ful bypass include the diameter of the artery
beyond the obstruction, the size and quality
of distal run-off and the presence or absence
of collateral vessels. However, the effect of

ACB on ventricular performance remains
controversial.1518
The purpose of this study was to test the
hypothesis that if, in spite of critical coro
nary artery stenosis or obstruction, myocar
dial perfusion, as assessed by the labelled
albumin-particle technique, was normal,
then left ventricular contraction if abnormal,
should improve with ACB surgery. We have
shown that ventricular performance as meas-

NORMAL
R EGION AL

ABNORMAL
M YOCAR DIAL
PER FUSIO N

Fig. 4.—Patient group with abnormal myocardial
perfusion scintiscans. These are subdivided into
two groups on basis of whether regional myocar
dial perfusion into which bypass graft was placed
was normal or abnormal.

Fig. 5.—Abnormal myocardial perfusion of right
coronary artery (A) and left coronary artery (B).
There is increase in proximal activity for right
coronary artery in keeping with mid-occlusion of
this vessel. B shows large perfusion defect in ante
rior wall.
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Fig. 6.—Preoperative (A, B) and postoperative (C, D) left ventricular angiograms of patient whose
myocardial scintiscan is shown in Fig. 5. A and C represent end diastole, and B and D represent end
systole. Anterolateral and apical akinesis present preoperatively is unchanged and perhaps worse in post
operative study. In addition, inferior-wall akinesis is present.

Fig. 7.—Postoperative myocardial perfusion scan of patient in Figs. 5 and 6. A is perfusion through
left coronary artery and B that through graft to left anterior descending coronary artery. C (combined
view of A and B) shows no change in perfusion to anterior wall in spite of patent ACB.
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LE FT

V E N TR IC U L A R

CONTR AC TIO N

Fig. 8.—Postoperative change in left ventricular
contraction on basis of normal or abnormal pre
operative test using MAA myocardial scintiscan.
Numbers refer to patients in each group.

ured by EF and wall-motion abnormalities
does improve in some patients. Although
this finding is not new, we have shown, with
use of the labelled albumin particles, that it
is possible to predict preoperatively which
patient is most likely to show improvement.
Regional myocardial perfusion as assessed
by the labelled albumin-particle technique
provides an evaluation of the patency of
small vessels of the myocardial vascular bed.
The distribution of the biodegradable par
ticles reflects the distribution of blood flow
to each region containing these particles and
can be detected by external radionuclide
imaging. Regional obstruction of blood flow
is associated with a corresponding area of
diminishing concentration of radioactivity in
the perfusion image. By this technique, if
the myocardial perfusion image is normal,
regardless of the degree of critical stenosis in
the coronary artery and in spite of abnor
malities in left ventricular contraction, the
patient has an adequate capillary bed and
should be a good candidate for ACB. Con
versely, if myocardial perfusion is absent
or markedly impaired, it is unlikely that the
patient will show an improvement in left
ventricular function after ACB surgery.
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INFLUENCE OF LEFT VENTRICULAR FUNCTION AND OTHER
PARAMETERS ON EARLY AND LATE MORTALITY
FOLLOWING CORONARY BYPASS SURGERY*
BERNARD R. CHAITMAN, MD, FRCP[C], MARTIAL G. BOURASSA, MD, ALAIN
HEITZ, MD and LUCIEN CAMPEAU, MD, FRCP[C]
Left ventricular performance, coronary anatomy
and postoperative clinical parameters of 66 con
trol patients (group I) randomly selected from
797 survivors of coronary bypass surgery were
compared with those of 45 patients who died
within 30 days of operation (group II) and 53 pa
tients who died late (average, 22 ± 2 mo)
(group III).
Average preoperative left ventricular end-di
astolic pressure, ejection fraction and mean cir
cumferential fibre shortening rate were signifi
cantly better in group I than in group III patients.
These same parameters were not significantly
different when group I was compared to group
II. Abnormal wall motion was significantly less
frequent in patients from group I than in patients
from groups II and III. Tripie-vessel disease was
present preoperatively in 40 (61%) controls com
pared with 37 (82%) early deaths (P = 0.021) and
35 (66% ) late deaths (NS). The number of grafts
placed per patient was not significantly different
in the three groups. Perioperative myocardial in
farction (M l) and low cardiac output syndrome
were the commonest causes of early death. Late
complications such as Ml and heart failure oc
curred in 4 (6 % ) v. 15 (3 2 % ) (P = 0.0006) and 4
(6 % ) v. 27 (57%) (P<0.0001) group I v. group III
patients, respectively.
Surgical expertise, preoperative ventricular
performance and triple-vessel disease are impor
tant determinants of early mortality following
bypass surgery and preoperative left ventricular
performance is one of the most important deter
minants of late mortality.
Les indices de la fonction ventriculaire gauche,
les donnees de la coronarographie et certains parametres cliniques post-operatoires de 66 pa
tients (groupe I) choisis au hasard a partir de
797 patients, sont confrontes a ceux observes
chez 45 patients decedes en dedans de 30 jours
apres chirurgie (groupe II) et 53 patients dece-

*From the Montreal Heart Institute, and the de
partment of medicine, University of Montreal,
Montreal, PQ.
Supported in part by a grant from the lean-Louis
Levesque Foundation.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct. 1823, 1976.
Reprint requests to: Dr. Bernard R. Chaitman,
Montreal Heart Institute, 5000 Belanger St. E,
Montreal, PQ HIT 1C8.

des tardivement (moyenne 22 ± 2 mois) (groupe
III), tous ayant subi des pontages aortocoronariens. La pression telediastolique gauche pre
operatoire, la fraction d'ejection et la vitesse
moyenne de raccourcissement des fibres myocardiaques sont statistiquement meilleurs dans
le groupe I par rapport au groupe III. Les memes parametres ne sont pas statistiquement
differents en comparant les patients du grou
pe I par rapport au groupe II. Des anomalies
de la dynamique ventriculaire sont moins frequemment observees dans le groupe I par rap
port au groupe II et III. En preoperatoire, une
atteinte des trois troncs coronariens a ete observee chez 40 patients (6 1 % ) du groupe I, chez
37 (82%) du groupe II (P=0.021) et 35 (66% ) du
groupe III (NS), le nombre de greffons par
patient a ete similaire en moyenne, soit pour les
trois groupes. La survenue d'infarctus du myocarde en periode perioperatoire est la cause la
plus frequente des deces precoces. Un infarctus
du myocarde, comme complication tardive, a ete
observe chez 4 patients (6 % ) du groupe I, et 15
patients (32% ) du groupe III (P = 0.0006); par
ailleurs, I’insuffisance cardiaque pour les memes
groupes etait presente chez 4 patients du groupe
I (6 % ) en regard de 27 patients du groupe III
(57%) (P < 0.0001).
A la suite de pontage aortocoronarien, les facteurs relies a la mortalite precoce sont I’expertise chirurgicale, la fonction ventriculaire pre
operatoire et la presence d’une atteinte des trois
troncs coronariens. Le facteur le plus discrimi
nant quant a la mortalite tardive a la suite de
cette chirurgie, est la fonction ventriculaire gau
che preoperatoire.

T h e effect of coronary artery bypass on lon
gevity and preservation of myocardial func
tion is unknown. The data presently available
are controversial,1-6 and in several reports
this may be related to the small numbers of
patients studied. With adequate numbers for
meaningful statistical analysis it should be
possible to have more definite information
to provide a guide in the selection of patients
for surgery. In this report, we have compared
objective assessment of left ventricular func
tion, coronary anatomy and postoperative
follow-up parameters in 45 patients who died
early and 53 patients who died late from
797 survivors.
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M a terial and M ethods

Patient Material
One thousand consecutive patients under
went aortocoronary bypass surgery at the
Montreal Heart Institute between Sept. 1,
1969 and Aug. 31, 1974. Almost all patients
had class III to IV angina pectoris (Cana
dian Cardiovascular Society [CCS] classifi
cation)7 and coronary artery stenoses equal
to or greater than 70% . One hundred and
five patients had associated cardiac proce
dures (valve commissurotomy or replace
ment, wall resection) and are excluded from
this report. Three groups of patients were
evaluated (Fig. 1). The control group (group
I) comprised 66 patients (59 men and 7
women; mean age, 50 ± 1.0 yr), alive in
January 1975 who were randomly selected
from 797 survivors. Nonsurvivors included
45 patients (36 men and 9 women; mean age,
52 ± 1.1 yr) who died within 30 days of
surgery (group II) and 53 patients (47 men
and 6 women; mean age, 51 ± 0.9 yr) who
died between 1 month and 5 years after
operation (group III). Late deaths were di
vided into cardiac-related (40 patients,
group Ilia) and noncardiac-related (13 pa
tients, group Illb) deaths. Forty patients
(18, 5 and 17 patients in groups I, II and III
respectively), operated on before 1972, had
associated internal mammary implants. This
procedure was abandoned at our hospital
after 1972.
Preoperative Evaluation
Selective coronary arteriography was per-

Fig, 1.—Total number of patients in each group
per year of operation. First, second and third col
umn in each year represent number of patients in
groups I, II and III, respectively. Interrupted lines
in columns (1969-72) show number of patients
with internal mammary implant. Table in upper
right corner lists total number of patients in each
group. ACBG = aortocoronary bypass graft, IM1
= internal mammary implant.
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formed by a percutaneous transfemoral ap
proach as described previously.8 Left ventri
cular pressures were measured and left ven
triculography was always done before coro
nary arteriography. The left ventricular enddiastolic pressure (LVEDP) was taken coin
cident with the peak of the R wave on the
electrocardiogram. Left ventricular cineangiograms were filmed in the right anterior
oblique position at 60 frames/s. The left
ventricular silhouettes were traced in end
diastole and in end systole by one experi
enced observer. Ventriculograms with fre
quent extrasystoles, inadequate opacification
or improper centring of the image were ex
cluded from analysis. The diaphragm was
traced and when external markers were un
available,!> the ribs or spine were traced to
provide an extracardiac reference system.10
Left ventricular wall motion was assessed by
visual inspection of the tracings and of the
left ventricular cineangiogram. Anterior in
ferior and apical segments of the left ventricle
were evaluated. For statistical purposes,
moderate to severe hypokinesis, akinesis and
dyskinesis were considered as abnormal wall
motion, and mild hypokinesis was considered
as normal wall motion. Ejection fraction
(EF) was calculated using a digital computer.
Left ventricular EF could be calculated pre
opera tively in 53 patients of group I, 28 pa
tients of group II and 38 patients of group
III. In 22 patients of group I and 10 of group
III the EF was calculated both before and
after operation; the latter calculation was
made at an average interval for the two
groups of 21.9 ± 2.9 and 17.6 ± 2.9 months,
respectively, following coronary revascular
ization. In all these patients left ventriculo
graphy was performed more than 2 months
postoperatively. Mean circumferential fibre
shortening rate (VCF) was determined from
the Karliner formula11 where, except in the
presence of mitral regurgitation, 50 ms is
subtracted to account for the pre-ejection
period. Cinecoronary arteriograms were in
terpreted by at least one of three experienced
cardiovascular radiologists. Each vessel was
filmed in four to six views.12 Stenosis was
recorded as severe when atherosclerotic nar
rowing was equal to or greater than 50%
of the intraluminal diameter. When the left
main coronary artery was involved, it was
considered to represent double-vessel in-
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volvement. The operative technique used in
preparation of the saphenous vein and tech
nical factors relating to aortocoronary anas
tomosis have been described previously.13
Postoperative Studies
Clinical and angiographic parameters
were recorded postoperatively. Functional
disability caused by angina was coded ac
cording to the CCS classification,7 which was
adapted from the New York Heart Associa
tion classification. In the CCS classification,
class I patients have angina during strenu
ous exertion but not during ordinary phys
ical activity; class II limitation occurs with
ordinary activity such as walking or climb
ing stairs rapidly; class III patients have
marked limitation of ordinary physical acti
vity such as walking one to two blocks on
the level and climbing one flight of stairs in
normal conditions and at a normal pace;
class IV patients cannot carry on any physical
activity without discomfort. Perioperative
myocardial infarction (MI) was diagnosed
when the 12-lead electrocardiogram (ECG)
taken within 48 hours of operation revealed
new Q waves greater than 0.04 seconds in
more than one lead. In many patients who
died early, autopsy findings suggested peri
operative MI. Postoperative late infarction
was recorded when a classic clinical history
was accompanied by increased cardiac en
zymes and electrocardiographic changes, or
when fresh infarction was documented at au
topsy. Most patients with symptoms of con
gestive heart failure had at least one hospital
ization accompanied by classic radiologic
features of left ventricular failure.
Coronary anatomy and graft status were
re-evaluated in 50 patients in group I and
41 patients in group III at an average in
terval of 14.5 ± 1.9 and 8.7 ± 1.9 months
after operation, respectively. When the graft
appeared occluded, selective injections were
usually made into the remaining stump, or a
bolus injection was made in the ascending
aorta showing the remaining stump or irreg
ularities of the aortic wall at the graft origin.
Progression of disease in the native coronary
anatomy was considered to have occurred
when a new lesion was present in a nonbypassed artery or distal to a bypassed vessel,
or when a preoperative lesion progressed
to subtotal or complete occlusion. For sta

121

tistical purposes, grafts with more than 50%
stenosis were considered to constitute an in
adequate result and were added to the oc
cluded graft category.
Autopsies were performed on 37 of the
45 patients in group II. A late clinical follow
up was possible for all control patients and
47 of the patients in group III at least 6
months before death. The cause of death
was determined from the Quebec Bureau of
Vital Statistics for all patients, including the
six patients who died late in whom a clin
ical follow-up was not possible. Forty of
the 53 late deaths were attributable to car
diac causes.
Statistical Analysis
Analysis of the parameters in group I were
compared statistically with those in groups
II and III, using Dunnett’s test and the har
monic mean.14 Analysis of nonparametric
results was performed using a Fisher’s exact
test.1 '>Patients in group Ilia were compared
with those in group 111b using an unpaired
Student’s t-test, or Fisher’s exact test in the
case of nonparametric comparisons.
R esults

Preoperative Left Ventricular Function
Patients who died early (group II) and
late (group III) following coronary bypass
surgery had a more severe degree of left
ventricular impairment. Abnormal inferior
and apical-wall motion occurred in 9 (15% )
and 13 (21%) of group I patients v. 14
(39%) and 17 (47%) of group II patients
(Fig. 2). Mean LVEDP was 11 ± 0.6 (mean
±
1 SEM) mm Hg in group I and 13 ± 1.4
mm Hg in group II. Mean E F was 0.49 ±
0.01 in group I and 0.45 ± 0.02 in group II.
Mean VCF was 0.76 ± 0.03 circumferences
per second (circ/s) in group I and 0.75 —
0.07 circ/s in group II (Fig. 3).
When patients who died late (group III)
were compared with patients in the control
group (group I), preoperative abnormalities
of wall motion were much more frequent in
group III. Abnormal motion of the anterior
wall was present in 15 (25% ) patients in
group I and 23 (46%) patients in group
HI (P = 0.027); defects of apical-wall motion
were observed in 13 (21% ) patients in
group I and in 29 (58% ) patients in group
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III (P = 0.0002); inferior wall-motion de
fects were seen in 9 (15%) group I patients
and in 26 (52% ) group I lf patients (P <
0.0001) (Fig. 2). Mean LVEDP was 11 ±
0.6 mm Hg in group I and 16.2 — 1.3 mm
Hg in group III (P < 0.001). Mean EF was
0.49 — 0.01 in group I and 0.41 ± 0.02 in
group III (P < 0.001). Mean VCF was 0.76
± 0.03 circ/s in group I and 0.53 ± 0.04
circ/s in group III (P < 0.001) (Fig. 3).
The difference in preoperative left ven
tricular performance was also significant
when the cardiac causes (group Ilia) of late
death were compared with the noncardiac
causes (group Illb). LVEDP was 17.4 ±
1.7 and 11.9 ± 1.6 mm Hg; EF was 0.38 ±
0.02 and 0.50 ± 0.03 (P<0.01) and mean

Fig. 2.—Significance of abnormal preoperative
left ventricular contraction as determinant of early
and late mortality following coronary bypass sur
gery. Abnormalities of wall motion were signifi
cantly more frequent in inferior and apical left
ventricular segments of group II patients than in
group I controls. Contraction abnormalities of an
terior (P = 0.0271), inferior (P < 0.0001) and
apical (P = 0.0002) ventricular segments were
more common in group III patients than in those
in group I. Among group III patients, wall-motion
abnormalities of inferior segment (P = 0.0236)
were more frequent in those who died of cardiac
than of noncardiac causes.
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VCF was 0.48 ± 0.04 and 0.66 ± 0.08
circ/s (P < 0.05), respectively (Fig. 3).
If patients having aortocoronary bypass
grafts alone were considered, the differences
were again significant. LVEDP was 11.8 —
0.7 mm Hg in group I and 16.6 ± 1.7 mm
Hg in group III (P < 0.005). The EF was
0.49 ± 0.02 in group I and 0.42 ± 0.03 in
group III (P < 0.02) and the mean VCF was
0.74 ± 0.04 circ/s and 0.56 ± 0.05 circ/s
(P < 0.01), respectively.
Postoperative Changes in Ventricular
Function

Of the 22 patients in group I studied 21.9
± 2.9 months after coronary revasculariza
tion, the average EF remained unchanged
from 0.51 ± 0.02 to 0.48 ± 0.04. Of the 10
patients in group III studied 17.7 ± 2.9
months postoperatively, the E F of 0.41 ±
0.06 v. 0.41 ± 0.08 also remained the same
(Fig. 4).
The average follow-up in group III was
22 ± 2 months compared with 30 ± 2
months in group I (P < 0.25). When the sur
vival time of group Ilia patients was averaged
with respect to the EF an important trend
became obvious (Table I); longevity was
directly related to the preoperative EF: of the
seven patients with an EF less than 0.30, the
survival time was 14.9 ± 3.6 months after
operation compared with 30.8 ± 5.3 months
for six patients having an EF greater than
0.50 (P < 0.05). The influence of poor left
ventricular function on late survival is eviLate d e a th (n = 10)
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Fig. 3.—Importance of preoperative left ventri
cular function as determinant of late mortality.
Indices of left ventricular performance were not
significantly different in group II patients from
controls. Among group III patients, left ventricular
end-diastolic pressure (LVEDP) was greater (P <
0.001), and ejection fraction (EF) (P < 0.001)
and mean circumferential fibre shortening rate
(VCF) (P < 0.001) were substantially lower than
in group I patients. EF (P < 0.01) and VCF (P <
0.05) were significantly lower in group Ilia than
in group Illb.

Mean fo llo w -u p

21.9 t 2.9 mo

Mean fo llo w -u p

17.6 t 2.9 mo

Fig. 4.—Surgical intervention does not lessen left

ventricular function in patients who die late after
coronary bypass surgery (group III). Left ventri
cular performance assessed by EF (mean ± 1 SEM)
did not change appreciably after operation in
groups I or III. Patient in group III whose EF de
creased from 0.50 to 0.31 after operation suffered
a myocardial infarction (MI) 2 months postoper
atively.
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TABLE I.— L ate D e a t h : A sse ssm en t

Ejection fraction

Objective
survival,
mo

0.30
0.31 - 0.49
0.50

14.9 ± 3.6
23.2 ± 3.8
30.8 ± 5.3*

of

E je c t io n F r a c tio n

No. of
patients
7
14
6

in
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G r o u p III a

Subjective
survival,
mo
13.8 ± 2.5
23.2 ± 3.8*
34.1 ± 5.2f

No. of
patients
14
14
9

*P < 0.05.
fP < 6.001.

dent. Markedly dilated left ventricles fre
quently could not be traced, so a subjective
appraisal of the EF was made. When a visual
appraisal of left ventricular function was
made, 14 patients with a predicted EF of less
than 0.30 lived for 13.8 ± 2.5 months com
pared with 9 patients with normal ventri
cular contraction who survived 34.1 ± 5.2
months postoperatively (P < 0.001).
Preoperative Coronary Anatomy
Triple-vessel disease was present in 37
(82%) patients in group II compared with
40 (61%) of those in group I (P < 0.0207).
Left main coronary artery disease occurred
in 11 (24%) patients in group II compared
with 7 (11%) in group I (P = 0.0676). If
patients having coronary bypass grafts alone
were considered, 32 (80%) in group II
compared with 28 (58% ) in group I had
triple-vessel disease (P = 0.0391).
The number of patients with triple-vessel
disease preoperatively was not significantly
different in group III from those in group I
(35 [66% ] v. 40 [61%]). Among patients in
group Ilia, 28 (74%) had triple-vessel dis
ease compared with 7 (54% ) patients in
group Illb.
Coronary Anatomy and Graft Follow-Up
The number of grafts placed was not signi
ficantly different in groups I, II, or III (1.89
± 0.10, 2.00 ± 0.12 and 1.72 ± 0.10, repectively). Nor was it significant when pa
tients having bypass grafts alone were con
sidered (2.13 ± 0.12, 2.05 ± 0.13 1.83 ±
0. 13, respectively). Graft status was known
at autopsy in 31 patients in group II. Fiftysix of 62 grafts (90%) were patent and free
of significant stenoses. When patients in
group III were compared with those in group
1, the number with at least one excellent
bypass graft and the number with progres
sion of native disease were not significantly

different (29 [71 %] v. 44 [88%] and 14
[34%] v. 13 [26% ], respectively).
When patients having bypass grafts alone
were considered, 18 (69%) of those in group
III compared with 31 (94% ) of those in
group I had at least one graft patent, and 8
(30%) patients in group III v. 7 (21% )
patients in group I had progression of their
native disease. The follow-up period in this
subgroup of patients was a mean of 5.8
months (range, 0.5 to 51 mo) for group III
and 12.4 months (range, 0.5 to 57 mo) for
group I.
Postoperative Clinical Parameters
Severe postoperative angina occurred in
19 (29% ) group I patients compared
Functional class

Perioperative infarction

Fig. 5.—Residual or recurrent angina pectoris
occurred in 24 (51% ) group III patients v. 19
(29%) group I patients (P = 0.0193). Incidence
of perioperative MI was similar in both groups.
Frequency o f late MI (P = 0.0006) and congestive
heart failure (P = 0.0001) was greater in group
III than in group I.
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with 24 (51%) group III patients (Fig.
5). When those having bypass grafts alone
are considered, this difference became more
marked (11 [23 %] and 19 [61%], respec
tively). In group I, eight (44% ) patients
with associated internal mammary implants
had residual or recurrent angina compared
with five (31%) patients in group II.
Perioperative MI occurred in six (9%)
control patients and four (8% ) patients
who died late. Four (6% ) patients in
group I had a postoperative MI compared
with 15 (32% ) patients in group III. MI
was a terminal event in all 15 group III
patients; MI was confirmed at autopsy in 9
of these patients.
There were 4 (6%) patients in group I
with congestive heart failure postoperatively
and 27 (57%) patients in group III
(P < 0.0001). Of the four patients in group
I two had failure before operation and in
two this complication developed de novo
postoperatively; one had a perioperative
MI and in the other heart failure occurred
subsequent to MI after the operative period.
Of the 27 patients in group III who suf
fered congestive heart failure, 18 had evi
dence of this complication preoperatively
and in 9 it developed postoperatively; 2 of
the 9 patients had a perioperative MI, and
heart failure developed in 4 subsequent to
MI after the operative period. There was no
obvious explanation for the heart failure that
developed in the remaining three patients.
Of the 27 patients in group III with post
operative congestive heart failure, 25 died
of cardiac causes.
Causes of Early and Late Mortality
Intraoperative MI and low-output syn
drome postoperatively accounted for 35
(78%) of the 45 early deaths (Table II). Of
these 45 patients, 18 died within the first 24
hours. The average time of death was 4 ± 1
days after operation. Autopsies were per
formed on 37 of the 45 patients. Cardiac
causes accounted for 40 (76% ) of the 53
late deaths (Table III). Fourteen patients
died of MI, and in nine MI was confirmed at
autopsy. The distribution of causes of late
death in the remaining 40 patients was ap
proximately equal. Autopsies were either
not performed or the results were unavail
able for 12 of the 13 sudden deaths.
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D iscussion

Statistical identification of risk factors that
relate to operative and late death following
coronary bypass surgery is often limited be
cause of the small numbers of patients stu
died. In many series, a quantitative evalua
tion of left ventricular performance frequent
ly is not done.1- 6- 10 in this report we have
studied the preoperative ventricular function
of 45 patients who died early (group II) and
53 who died late (group III) after coronary
bypass surgery; these patients have been
compared with a cohort of 66 patients ran
domly selected from 797 survivors.
Many authors have reported an increased
operative mortality in patients with severe
left ventricular dysfunction3-3- 17-19 and
triple-vessel disease.-- 4 In our series of early
deaths, abnormal motion of the left ventri
cular wall and triple-vessel disease were sta
tistically more frequent than in the control
group. Other parameters such as decreased
EF and increased LVEDP were not signifi
cantly different from the controls. All ventri
culograms in this series were filmed in the
six-inch mode and the ventricular outlines
of markedly dilated ventricles could not be
traced. This may account for notable im
pairment of left ventricular contraction ass
essed by wall-motion abnormalities but not
by EF. The commonest cause of early death
TABLE II.—C auses of E arly M ortality (< 3 0
D ays), G roup II* (n = 45)
Cause

ACBG

ACBG + I M I Total

Arrhythmia..............
Low o u tput..............
Myocardial
infarction..............
Bleeding....................
Embolism.................

2
15

0
4

2
19

16
6
1

0
1
0

16
7
1

T o tal.........................

40

5

45

*ACGB = aortocoronary bypass graft, IM I =
internal mammary implant.
TABLE III.—C auses of L ate M ortality, G roup
III (n =53)
Cause

ACBG

ACBG + IM I Total

Sudden d eath . . . .
Myocardial
infarction..........
Congestive failure
Noncardiac..........

7
9

6
5

13
14

10
10

3
3

13
13

T o ta l.....................

36

17

53
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was perioperative MI and low-output syn
drome. Other reports have also listed intra
operative MI as the commonest cause of
operative mortality in coronary bypass sur
gery.3' 20 In this study the number of grafts
placed per patient was the same in the pa
tients with early deaths as in the control
group of patients, and graft patency at au
topsy was 90%. It is not clear when MI
occurs during a coronary bypass operation.
The high percentage of patent grafts found at
autopsy in group II indicates that perioper
ative MI is not prevented by having perme
able grafts. Operative mortality in coronary
bypass surgery has been shown to decrease
in different centres as the experience of the
surgical team increases. 20 The decrease
in operative mortality may be explained by
better patient selection or by greater tech
nical expertise exhibited by various surgical
teams. We would conclude that there are
several causes of operative mortality, and
depressed ventricular function is one. Peri
operative technical factors, for example, may
play a major role; we did not assess this fac
tor in our study except for documenting the
occurrence of perioperative MI.
Poor preoperative left ventricular per
formance was the most important parameter
relating to late mortality. Preoperative EF
and mean VCF were significantly decreased
and abnormal left-ventricular-wall motion
and LVEDP were significantly increased in
patients in group III. Other preoperative pa
rameters, such as the number of stenotic
vessels and the number of grafts placed per
patient, were similar in groups I and III.
The incidence of perioperative MI was simi
lar in group I (9%) and in group III (8%)
to that reported in the literature.21 Thus,
among the preoperative parameters evalu
ated in this study, poor left ventricular func
tion was the most important determinant of
late mortality. When group III was subdi
vided into patients dying of cardiac and non
cardiac causes, ventricular performance in
the patients with cardiac-related deaths was
significantly diminished. The importance of
preoperative left ventricular performance as
a determinant of late mortality has been con
firmed in other studies as well.5' u- 22-24
Several authors have reported that left
ventricular function is not appreciably
changed 6 months to 1 year after coronary
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bypass surgery providing there has been no
intervening M I.23'28
No data are available on postoperative left
ventricular performance in patients who
have died late after coronary bypass surgery.
We were able to re-evaluate left ventricular
EF in a small number of the patients in
groups I and III. There was no significant
difference in EF after operation in either
group. Thus, in evaluating the significance
of left ventricular function on late mortality,
preoperative ventricular performance ap
pears to be the important factor, caused by
the surgical intervention itself.
The postoperative course of the patients in
group III was characterized by a greater in
cidence of residual or recurrent angina pec
toris and MI than in group I patients. This
could not be related to the number of pa
tients who had occluded grafts at postoper
ative angiography or progression of disease
in the native circulation, or both; the inci
dence was similar in both groups. However,
coronary and graft arteriography were per
formed an average of 6 months later in group
I patients and the results represent cumula
tive graft patency and not consecutive serial
data (late angiographic follow-up was limited
to 2 weeks in 51% of group III patients v.
24% of group I patients).
Postoperative congestive heart failure was
significantly more common in group III
than in group I. This was related to the pre
operative clinical status. We know this be
cause heart failure persisted in 18 patients
in group III who had congestive heart fail
ure before operation. Our results show that
late survival following coronary bypass sur
gery is strongly influenced by the preoper
ative status of the left ventricle and does not
appear to be improved in patients with poor
left ventricular function. Moreover, patients
in group III had more frequent residual an
gina and a greater incidence of MI after by
pass surgery than did the patients iir group
I. These data suggest that surgery for relief
of angina and prevention of MI in patients
with significantly impaired left ventricular
function may not always be successful. Cer
tainly, one should not rely too much on these
secondary benefits when recommending sur
gery to such patients.
Preoperative left ventricular performance
is the most important factor relating to late
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mortality following bypass surgery. Other
factors such as late progression of disease in
the native circulation and long-term viability
of grafts may also be important, but require
further study. Coronary atherosclerosis is a
progressive disease. Surgical palliation of
symptoms is an admirable goal in suitable
patients with good or slightly impaired left
ventricular function who are incapacitated
despite medical therapy. Whether coronary
artery bypass will influence longevity, or pre
serve myocardial function, will not be
known until the long-term results of prospec
tive randomized studies to evaluate medical
and surgical therapy are reported.
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in
Hyperfibrinolytic
Hemorrhages

Trasylol, in its role as an
antifibrinolytic agent, inhibits
both plasmin and the
plasminogen activator.

Synthetic antifibrinolytic
agents inhibit only the
plasminogen activator.

Trasylol is indicated for prim ary and generalized, secondary
hyperfibrinolytic hem orrhages with and w ithout the shock
syndrome. S econdary hyperfibrinolysis follo w in g
intravascular clottin g may require heparin a n d /o r
fibrinogen replacem ent in addition to Trasylol.
W ith Trasylol, the an tifibrinolytic agent w ith
sim ultaneous anti-coagulant (a nti-th rom bop lastic)
effect, there w ill not be a dangerous shift
in the equilibrium between
the clotting and the lysis system
in favour of coagulation.
Synthetic a n tifib rin o lytics
are contraindicated if the re is
evidence of active intravascular
coagulation. Trasylol is indicated
in all cases of hyperfibrinolysis,
w hether a differential diagnosis
has been made or not.
FBA Pharmaceuticals Ltd.
D istributed by:
B o e h ring e r Ingelheim (C a n a d a ) Ltd.

Vol. go

THE CANADIAN JOURNAL OF SURGERY

130

Trasylol
• increases the chances
of survival in acute
pancreatitis
• prevents the enzymatic
release of toxic
polypeptides and kin ins
• stops hyperfibrinolytic
hemorrhage
Indications and Dosage

Hyperfibrinolytic Hemorrhage
T h e se c o n d itio n s o c c u r in s u rg e ry ,
including open heart surgery, prostatic
su rg e ry and p a th o lo g ic a l o b s te tric a l
bleeding conditions, such as in abruptio
placentae.
Initial dosage: 200,000 — 500,000 K.I.U.
of w hich 200,000 K.I.U. should be given
by intravenous injection (a t a rate not to
exceed 5 ml per minute), the rest if neces
sary by slow infusion. A d m in is tra tio n
should be co n tin u e d up to 1,000,000
K.I.U. per day until the hemorrhage has
been arrested.

Pancreatitis
Initial dosage: 100,000 — 200,000 K.I.U.
to be follow ed by 100,000 K.I.U. every
six hours fo r a period of 4-5 days. The
drug is adm inistered e ith e r by intraven
ous injection (at a rate not to exceed 5
ml per minute) or by slow lnfusion.
Warnings and Precautions
Trasylol is a polypeptide and thus may
act as an antigen. Although adverse reac
tions due to hypersensitivity have been
described infrequently, this possibility
should always be kept in mind. In patients
w ith a h is to ry of h y p e rse n sitivity, the
usual precautions for the prevention and
a rre st o f a lle rg ic re a c tio n s sh o u ld be
observed p rio r to the adm inistration of
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml
a m p u ls c o n ta in in g 1 0 0 ,0 0 0 K .I.U . in
boxes of 5 ampuls.
Trasylol® Product Monograph is available
on request.

The object of

Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.

Distributed by:
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P1J3

GLIMPSES OF SURGICAL HISTORY:
N FOR NEEDLES
DAVID A. E. SHEPHARD

NEEDLES are among the most ancient of
surgical instruments, but man the hunter used
needles long before man the surgeon used
special tools. Man early developed implements
as extensions of his fingers, and the need for
the hunter to probe wounds and remove
foreign bodies certainly led to the invention
of needles of one type or another. Domestic
chores were facilitated by needles and thread,
and needles similar to the flat, eyed surgical
needles of today have been found alongside
obviously domestic tools in ancient archeologic
sites. Needles used to make nets and to stitch
together the hides making a tent were soon
adapted by early surgeons in their work of
healing.
Wounds required suturing; cysts, abscesses
and piles needed evacuating; and extraneous
objects in the integument and eye had to be
removed. The Hindus, the Greeks, the Romans
and the Arabians perfected the surgical needle
for a variety of purposes; Albucasis’ treatise
on surgical instruments, in particular, illus
trated the usage of needles and their applica
tion to delicate work such as treatment of
cataract. These ancient needles, however, were
all solid; none was hollow.
The relatively late development of the
hollow needle is perhaps surprising, for the
need to extract blood from piles, for example,
was recognized by the Hindus, who also
developed hypodermic medication - albeit by
scarifying the skin with a knife or razor and
rubbing in ointment manually and Wren,
the English architect, used quills in injecting
opium in 1656. Primitive syringes, too, were
known to Albucasis among others. The hypo
dermic needle and syringe were not invented
until the mid-19th century; credit being given
for their contributions to Lafargue (1836) and
Taylor and Washington (1839), and especially
Wood (1843), Rynd (1845) and Pravaz
(1851). Man the hunter and then man the
surgeon was now man the 19th-century tech
nologist, the initiator of so many remarkable
advances in surgery and other fields of human
endeavour.
-
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PERCUTANEOUS INSERTION OF A PERMANENT TRANSVENOUS
PACEMAKER ELECTRODE THROUGH THE SUBCLAVIAN VEIN*
ARTHUR FRIESEN, MD, GEORGE J. KLEIN, MD, FRCP[C], WILLIAM J. KOSTUK,
MD, FRCP[C] and SURAJ P. AHUJA, MD, FRCP[C]
Insertion of transvenous permanent pacemaker
leads through the subclavian vein is relatively
safe and simple. This procedure was performed
in 29 patients. The only serious complication was
dislocation of the lead in eight patients. With this
technique the endocardial lead can be positioned
quite readily in the right ventricle. Use of the
technique should be considered whenever the
cephalic vein cannot be located readily or is too
small to permit placement of an endocardial
lead.
L'insertion par la veine sous-claviere des deri
vations d'un stimulateur cardiaque transveineux
permanent, est reiativement sure et simple. Cette
procedure a ete realisee chez 29 patients. La
seule complication serieuse rencontree, a ete la
dislocation de la derivation chez 8 patients. Par
cette technique, la derivation endocardiaque peut
etre placee assez facilement dans le ventricule
droit. Le recours a cette technique devait etre
envisage chaque fois que la veine cephalique ne
peut etre facilement localisee, ou qu'elle est trop
petite pour permettre la mise en place d'une de
rivation endocardiaque.

P atients

and

Methods

Patients

Between Nov. 1, 1975 and Oct. 31, 1976,
leads for permanent pacing were implanted
through the subclavian vein in 29 patients
(16 men and 13 women; average age, 70,1
yr). Their disorders are listed in Table I.
The endocardial lead was a unipolar Med
tronic lead, model 6909-58 (Medtronic Inc.,
Minneapolis, MN), while the pulse genera
tors implanted were Medtronic models 5951
and 5961.
Surgical Technique

Under local anesthesia and with aseptic
technique, a small 3-mm incision is made
about 1 cm below the clavicle and 2 cm la
teral to the mid-clavicular line, similar to the
method of Loskot, Michaljanic and Klusil.8
The subclavian vein is located by directing an
18 or 20 gauge needle through the incision,
E ndocardial pacing was first reported in immediately under the clavicle towards the
the early 1950s by Callaghan and Bigelow1 suprasternal notch; this prevents laceration
who used endocardial atrial electrodes in of the vein or damage to adjacent structures.
animal experiments. Right ventricular endo Once the vein is located, the needle is with
cardial pacing was first reported in 1959 by drawn and a 14 gauge needle introduced
Furman and Robinson.- Transvenous per in a similar fashion. A 35-cm spring guide
manent endocardial pacing is now the pre is introduced through the needle and the
ferred method.3 One of the technical diffi needle withdrawn. A 15-cm Teflon dilator
culties in positioning transvenous endocar and a 10-cm no. 9 French Desilets-Hoffman
dial leads has been the accessibility of suit radiopaque sheath are introduced over the
able venous channels. The most commonly spring guide into the subclavian vein. With
used vessels are the cephalic vein, found in the patient holding his breath, the guide and
the deltopectoral groove,4 and the internal dilator are withdrawn and the pacemaker
and external jugular veins,5 but each may lead rapidly introduced through the sheath.
be difficult to find or cannulate, or both. Once the lead has been advanced into the
The subclavian vein has been used,0- 7 occa superior vena cava, the sheath is withdrawn,
sionally. In this report we describe the tech cut longitudinally with a pointed scalpel and
nique and results of permanent lead place removed. The proximal end of the lead is
then tunnelled subcutaneously to the pulse
ment through the subclavian vein.
generator pocket. The endocardial lead is
*From the cardiac investigation unit, University positioned in the right ventricular cavity;
Hospital, London, Ont.
Presented at the annual meeting of the Canadian when the pacing and sensing thresholds are
Cardiovascular Society, Edmonton, Alta., Oct. adequate the lead is sutured to the underly
18-23, 1976.
ing tissue with three to four silk sutures. The
Reprint requests to: Dr. William J. Kostuk, Car lead is then attached to the pulse generator,
diac investigation unit, University Hospital, 339
which is placed in the pulse-generator pocket,
Windermere Rd., London, Ont. N6A 5A5.
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and both are sutured to the underlying tissue.
Alternatively, the subclavian vein has been
punctured from within the pocket incision in
a similar fashion; this simplifies the tech
nique because the lead does not require tun
nelling into the pocket.
R esults

We have found the insertion of a perma
nent transvenous pacemaker lead through
the subclavian vein both simple and safe.
The major complication was dislocation of
the endocardial lead; repositioning was re
quired in eight patients (Table I). Three of
the lead displacements occurred within 10
days of placement; two patients had enlarged
right ventricular chambers and subsequently
required epicardial leads. Five lead displace
ments occurred late — 3 weeks to 7 months
after implantation. In all cases, lead reposi
tioning was readily performed without diffi
culty. In one patient the lead was inadver
tently damaged during repositioning. The
TABLE I.—D iagnosis
Patient no.

damaged lead was cut and a no. 9 French
Desilets-Hoffman sheath was passed over the
damaged lead into the subclavian vein. The
old lead was then withdrawn and replaced
by a new lead through the sheath without
need for additional puncture. Another pa
tient, who was a ‘twiddler”,9 displaced her
endocardial lead back into the pocket. No
hematoma or bleeding was noted. A new
lead was inserted without difficulty through
a fresh subclavian puncture via the original
pocket incision.
In one patient, a small asymptomatic
pneumothorax was noted on a routine follow
up chest radiograph. This required no the
rapy and cleared spontaneously.
On two occasions, we were unable to
puncture the subclavian vein. The first fail
ure occurred in an elderly, cachectic woman
in whom the subclavian artery was punc
tured; the needle was withdrawn and no
bleeding was noted. This incident occurred
early in our experience and prompted us to
abandon further attempts in that patient to

for and C omplications of Subclavian
in 29 P atients from N ovember 1975 to

Age and sex

Vein E ndocardial L ead P lacement
October 1976

Diagnosis

1
2
3
4
5

81
60
66
79
67

M
F
M
F
M

T achycardia-bradycardia
T achycardia-bradycardia
Complete heart block
Complete heart block
Complete heart block

6
7
8
9

76
78
59
52

M
M
F
F

Stokes-Adams attacks
Stokes-Adams attacks
T achycardia-bradycardia
T achycardia-bradycardia

10
11
12
13
14
15
16
17

60
83
77
84
42
82
62
74

M
F
F
F
M
F
M
M

Complete heart block
Sinus arrest, RBBB,* LAHf
Complete heart block
Complete heart block
Stokes-Adams attacks
Complete heart block
T achycardia-bradycardia
Complete heart block

18
19
20
21
22
23
24
25
26
27
28
29

72
51
84
73
74
82
82
71
80
68
55
58

M
F
M
F
M
F
M
M
F
M
F
M

Stokes-Adams attacks
Severe bradycardia
Complete heart block
Sick sinus syndrome
Sick sinus syndrome
Complete heart block
Complete heart block
T achycardia-bradycardia
Complete heart block
Trifascicular block
T achycardia-bradycardia
Complete heart block

*RBBB = right bundle branch block.
fLAH = left anterior hemiblock.
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Complications
____

Repositioning at 6 wk
—

_
Repositioning a t 3 mo
(x 2) — epicardial

_

Repositioning a t 7 mo
Repositioning a t 10 d
Repositioning at 1 d —
epicardial
—

“Twiddler” — 3 wk

_
_
____

Repositioning a t 3 wk, 3 mo
Repositioning a t 6 d
Asymptomatic pneumothorax,
repositioning
____
____
____

_
—
____

_
____
____
____

_
—
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find the subclavian vein. The second failure
was in a confused, agitated man in whom
localization of the subclavian vein was not
possible because of continuous shoulder
movements.
No other complications, such as myocar
dial perforation, air embolization, skin ero
sion, lead fracture or infection, occurred.
D iscussion
The external jugular4- ll’"1- and cephalic4- «• 11-1:4 veins have been the most fre
quently selected sites for insertion of perma
nent pacemaker leads. Each site has its draw
backs. The cephalic vein may be difficult to
find or too small to cannulate, or both. The
external jugular vein, though easier to find,
may be associated with a greater number of
lead fractures as a result of the sharp bend
of the lead on entry into the vein.14 More
over, use of the jugular vein requires tun
nelling of the lead either under or over the
clavicle in order to reach the site of the pulse
generator; this may make repositioning diffi
cult.
The subclavian vein, on the other hand,
is readily found and easily cannulated. Its
close proximity to the infraclavicular pulsegenerator pocket removes the need for sub
cutaneous burrowing if the vein is punctured
from within the pocket.
The lead may be passed into the subcla
vian vein either percutaneously or through
the generator incision. Once the vein has
been cannulated, the lead is usually placed
into the right ventricle within minutes. This
is advantageous in the elderly debilitated pa
tient who frequently is unable to lie still for
long periods of time. The procedure is safe
in the hands of an individual with experi
ence in cannulating the subclavian vein.
Furthermore, the same site may be used more
than once, obviating the need to search for
vessels.
Subclavian vein puncture has been asso
ciated with a number of potential problems:
pneumothorax, air embolism, arterial cannulation and laceration, hematoma formation
and difficulty in finding the vessel. These
complications, however, are infrequent in
experienced hands. Use of a small-bore nee
dle to locate the vein initially reduces the
risk of complication.
Asymptomatic pneumothorax occurred in

13 3

one of our patients; it resolved without the
rapy. This problem is most likely to occur
during the search for the vein, and may be
avoided by sliding the needle immediately
below the clavicle toward the suprasternal
notch. Uncooperative patients and patients
with severe pulmonary disease may be at
greater risk for this complication.
Air embolism did not occur in our series;
it may be avoided by careful instructions to
the patient to exhale or hold his breath while
the spring guide or endocardial lead is in
serted into the subclavian vein.
In two patients the subclavian vein could
not be found. The first patient was an elder
ly cachectic woman in whom there appeared
to be insufficient space between the clavicle
and ribs to reach the subclavian vein. At this
time, the subclavian artery was punctured
and the needle immediately withdrawn. The
patient had no symptoms and no detectable
hematoma developed. The second failure
occurred in an agitated and confused man
who was unable to control breath holding
and excessive shoulder movements. In this
setting, the risk of lung puncture, air em
bolism or vessel laceration may be high.
A major concern in the present series was
the high incidence of lead dislocations. The
lead is inserted through the muscle and
connective tissue layers into the subclavian
vein, through a region of relatively loose
tissue with none of the snug walls to “hold”
the lead as the cephalic vein might have.
This explains the higher incidence of dis
placement due to lead movements at the
site of insertion. Indeed, it may have played
a role in the early displacements. In an at
tempt to correct this problem we secure the
lead to the underlying tissue with three to
four separate silk sutures. Since this refine
ment was added there have been very few
displacements.
This method of insertion of permanent
pacemaker leads should be considered when
ever the cephalic vein cannot be readily lo
cated or is too small to permit placement of
a permanent endocardial lead.
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MYOCARDIAL INFARCTION FOLLOWING CORONARY ARTERY
BYPASS: FACTORS INFLUENCING ITS OCCURRENCE*
P. BEDARD, MD, FRCS[C], H. MARCINEK, MD, B. MORTON, MD, FRCP[C],
F. SMITH, MD, FRCP[C], Y. AKYUREKLI, MD, FRCS[C], M. BRAIS, MD, FRCS[C]
and W. J. KEON, MD, FRCS[C]
The authors have undertaken a prospective study
on postoperative myocardial infarction (P M I)
follow ing coronary artery bypass (C A B ) grafting.
P M I w as diagnosed from electrocardiographic
findings by the criteria of the Am erican Heart
A ssociation. From Aug. 1, 1975 to Feb. 27, 1976,
198 patients (177 men, 21 women) underwent
C A B . Their ages ranged from 31 to 71 ye ars
(mean, 49 yr). Of these patients, 18 ( 9 % ) s u s 
tained a PMI.
A num ber of factors were analyzed to deter
mine their influence on the occurrence rate of
PMI. Preoperative factors such as the New York
Heart Association classification, m easurem ent
of left ventricular function and evaluation of
the severity of coronary artery d isease were not
helpful in predicting a predisposition to PMI.
Endarterectomy w as the only operative inter
vention associated with a higher incidence of

*From the University of Ottawa cardiac unit,
Ottawa Civic Hospital, Ottawa, Ont.
Supported by the Ontario Heart Foundation.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct. 1823, 1976.
Reprint requests to: Dr. P. Bedard, Division of
cardiothoracic surgery, Ottawa Civic Hospital,
1053 Carling Aye., Ottawa, Ont. K1Y 4E9.

P M I (1 8 % ). Other factors su c h a s the interval of
cardiac anoxia and cardiopulm onary b y p a ss and
the number of v e s s e ls grafted did not se e m to be
associated with PMI. Low blood flow ( < 4 0 ml/
min) through the graft could be correlated with
the area of infarction in only 5 of 18 patients.
Am on g the operated patients, postoperative
ventricular arrhythmia w as m uch more com m on
in patients with PMI. The hospital m ortality in
this group w as 1 1 % (two patients).
Les auteurs ont entrepris une etude prospective
des infarctus postoperatoires du m yocarde (IP M )
consecutifs a un pontage aortocoronarien (PAC).
LTPM a ete diagnostique se lo n les crite re s de
I'Am erican Heart Association, a partir d es traces
electrocardiographiques. Du m o is d'aout 1, 1975
a fevrier 27, 1976, 198 patients (177 h o m m e s et
21 fem m es) ont regu un PAC . Leur age variait de
31 a 71 ans (49 ans, en m oyenne). De c e s pa
tients 18 (9 % ) ont subit un IPM .
Un certain nom bre de fa cte u rs a ete analyse
afin de determiner leur influence su r la frequen
ce des IPM . C ertains facteurs preoperatoires tels
que la m esure de la fonction ventriculaire gau
che, la New Y ork Heart A sso c ia tio n cla ssific a 
tion, et 1'evaluation de la gravite de la maladie
coronarienne, n 'on t ete d 'au cu n se c o u rs pour
predire les pre-dispositions a ITPM .

136

THE C A N A D IA N JO U R N A L OF SU RG ER Y

L'endarterectomie a ete la seule intervention
chirtfrgicale associee a une plus haute frequence
d’lPM. D'autres facteurs, tels que I'intervalle
d'anoxie cardiaque et de derivation cardiopulmonaire et le nombre de vaisseaux greffes, n'ont
pas semble influencer la frequence de I'lPM. Un
faible debit du greffon (40 ml/min) peut avoir
eu une correlation avec la surface de I'infarctus
chez seulement 5 des 18 patients.
Parmi les patients operes, I’arythmie ventriculaire postoperatoire a ete beaucoup plus frequente au sein du groupe IPM. La mortality chez
les patients hospitalises de ce groupe a ete de
11% (deux sujets).

study was undertaken on a prospective
basis to establish the factors that may influ
ence the incidence of postoperative myocar
dial infarction (PMI) after coronary artery
bypass (CAB) surgery. The incidence and
severity of myocardial injury following CAB
surgery becomes an important consideration
in evaluating its effect on the relief of angina,
the incidence of subsequent myocardial in
farction and the improvement in survival.1' 3
The purpose of the study was to discover
the clinical, laboratory and radiographic
factors in the patient before, during and
after operation that might help to predict a
susceptibility to PMI.
T h is

M ethod

From Aug. 1, 1975 to Feb. 27, 1976, 198
consecutive patients receiving CAB grafts
were followed at the University of Ottawa
cardiac unit. There were 177 men and 21
women; their ages ranged from 31 to 71
years (mean, 49 yr). Coronary angiography
and cardiac ventriculography were per
formed on all patients before operation.
However, postoperatively, coronary angio
graphy was not performed as a routine. All
patients had standard 12-lead electrocardio
grams taken before operation, at 2 hours
after and again at 1, 2, 3 and 10 days after
operation. Myocardial infarction was diag
nosed from the electrocardiographic find
ings, and the criteria for such a diagnosis
were based on the American Heart Associa
tion4 recommendations, depending for the
most part on the appearance of new Q
waves.4' 7 Cardiopulmonary bypass was car
ried out using a disposable oxygenator with
hemodilution, normothermia and a highflow technique. Normothermic cardiac arrest
was used for the distal anastomosis.
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Statistical analysis was obtained by com
paring the noninfarct and infarct groups on
the basis of preoperative, intraoperative and
postoperative factors. / - values were ob
tained for independent variables for both
groups. Yates correction was applied and P
values were then arrived at. Only values be
low 0.05 were considered significant.
R esults

Of the 198 patients studied, 18 (9%) sus
tained a PMI, giving two study groups: 180
patients without PMI (group 1) and 18 pa
tients with PMI (group 2).
Preoperative Status
Clinical assessment included age, indica
tion for surgery (Table I) and classification
according to the New York Heart Associa
tion (NYHA). The average age of both
groups was the same (49 yr). Similar propor
tions of both groups were operated on for
stable angina. Unstable angina was the in
dication for operation in 18 patients; 1 suf
fered a PMI. Four patients with an unstable
myocardial infarction were operated upon;
two had evidence of an extending infarction
postoperatively. The average NYHA classi
fication for both groups was class III — an
gina with mild exertion.
The preoperative hemodynamic data
were evaluated and both left ventricular
end-diastolic pressure (LVEDP) (10.8 mm
Hg) and aortic mean pressure (100 v. 96 mm
Hg) were similar in both groups. Preoper
ative coronary angiographic data are anal
yzed in Table II. On average, the degree of
stenosis of the vessels operated upon was 75
to 95% in both groups. Left main vessel dis
ease occurred in three (1.6%) patients in
group 1 and two (11%) patients in group 2.
Comparable figures were obtained in the pre
sence of triple-, double- and single-vessel
TABLE I.—P reoperative C linical D ata
Group 1
Indications for
operation

Number
(and %)

Group 2
'

Number
(and %)

Stable angina........................ 160 (89)
Unstable angina................... 17 (9.5)
Congestive heart failure. . .
1 (0.5)
Acute myocardial infarction 2 (1.0)

15 (84)
1 ( 5)
—
2 (11)

T o ta l....................................... 180

18
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T A B L E II.— Analysis of P reoperative C oronary Arteriography

Group 1

Group 2

Extent of disease

Number
(and %)

Number
(and %)

L eft m ain coronary a rte ry ..
T riple-vessel.........................
D ouble-vessel.......................
Single-vessel.........................

3
120
41
16

T o ta l.......................................

180

( 1)
(67)
(23)
( 9)

2 (11)
14 (78)
2 (11)
18

disease. Left ventricular function was asses
sed by LVEDP and ventriculography in the
right anterior oblique position. The left ven
tricle was divided into four segments show
ing dysfunction in the form of hypokinesia,
akinesia or dyskinesia. The left ventricular
classification was not significantly different
(2.7 v. 2.2).
Intraoperative Status
In Table III the factors involved in assess
ing cardiopulmonary bypass are shown. The
duration of cardiac anoxia was 28.6 min
utes in group 1 and 27.7 minutes in group 2.
Performance of the pump was analyzed in
terms of perfusion pressure and perfusion
time; these were similar in both groups. The
perfusion was gauged by urinary output, in
which the differences were insignificant, and
by the incidence of acidosis. In our series no
patient required treatment for acidosis dur
ing or after use of the pump. The plasma
hemoglobin value was interpreted as a re
flection of the pump’s ability to hemolyze;
again similar values were found in both
groups.
In both groups patients received an aver
age of 3.3 grafts. Of considerable interest,
however, are the patients who underwent en
darterectomy; usually this involved the right
coronary artery. Of our 198 patients, 50
underwent endarterectomy and 9 of these
sustained a PMI — an incidence of 18% v.
9% in the total study population. Endarte

rectomies were performed in 50% of the
group 2 patients and 22% of the group 1
patients; this difference was statistically
significant (P < 0.025,
= 5.06).
Another facet of the intraoperative data
examined was that of blood flow through
the graft (Fig. 1); the mean flow in both
populations was comparable. In addition,
the percentage of grafts with flows less than
40 ml/min was similar. In the case of the
posterolateral artery, in which the flow was
significantly different, the bias favoured the
infarct group in which no graft had a flow
less than 40 ml/min. Low graft flow ( < 40
ml/min) correlated with the area of infarc
tion in only 5 of the 18 patients.
Postoperative Status
The last set of data to be analyzed was the
postoperative data including bleeding, ex
ploratory thoracotomy, arrhythmias and
mortality (Table IV). The average volume of
postoperative bleeding (group 1, 0.96 /;
group 2, 0.84 /) and the incidence of ex
ploratory thoracotomy were similar in groups

Fig. 1.—Intraoperative d a ta indicating blood flow
per graft (m l/m in ) for various vessels. Mean blood
flows with standard deviation are shown. P ercen t
age of grafts with flows less than 40 m l/m in is
indicated. RT = right coronary; L A D = left a n 
terior descending; M-C = m ain coronary; P-L =
posterolateral; D IA G . = diagonal.

T A B L E III.— I ntraoperative D ata on C ardiopulmonary B ypass*
Parameter
Interval of cardiac anoxia (min)
Perfusion pressure (mm H g )..................
Perfusion tim e (m in)................................
U rine o u tp u t (/)■_■..................................
Plasm a hemoglobin (g /d l)......................
*A11 d ata are expressed as mean ± SD.

Group 1
(n = 180)
28.6
65.1
61.6
0.9
47.3

± 10.0
± 9.0
± 25.4
± 0.5
± 49.8

Group 2
(n = 18)
27.7
63.5
66.5
1.1
53.2

± 13.9
± 9.3
± 25.6
± 0.6
± 36.8
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TABLE IV.—P ostoperative D ata

Complications and procedures

Group 1 {n = 180)

Group 2 (n = 18)

Number (and %)

Number (and %)

Statistical
significance

9 ( 5)

0 (0)

—

Exploratory thoracotomy..........
Arrhythmias
Supraventricular.....................
Ventricular...............................

120 (66)
33 (18)

14 (77)
9 (50)

Hospital d eath .............................

3 (1.7)

2 (11)

1 and 2, as was the occurrence of supraven
tricular arrhythmias. Ventricular arrhyth
mias occurred in a higher proportion of pa
tients in group 1 than in group 2. The hos
pital mortality was 1.7% (three patients) in
group 1 and 11 % (two patients) in group 2.
D iscussion
The PMI of 9% places our study in ap
proximately the mid-range of reported inci
dence of myocardial infarction. 1' :{- 8-13
However, our study conflicts with data from
other centres in many important aspects.
First, it has been suggested that preoperative
functional classification has a role to play
in PM I.1' 3 In our study we have shown that,
except for patients with a history of preoper
ative myocardial infarction, clinical assess
ment and NYHA classification is of no pre
dictive value in establishing which patients
are likely to suffer a myocardial infarction.
In addition, our data show that unstable an
gina has no role in predisposing patients to
PMI. Four patients were operated on be
cause of an acute unstable infarction and
two of them showed evidence of an extension
of their infarction.
Our study also showed that preoperative
angiographic data are not helpful in predict
ing myocardial infarction, except in disease
of the left main coronary artery in which PMI
occurred in two patients. These findings
agree with those of Brewer, Bilbro and Bar
tel1 who, on comparing infarct and nonin
farct groups, found no significant difference
in risk factors, in hemodynamic data, or in
the number of diseased vessels. There is dis
agreement in the literature, however; Rose
and colleagues0 and Flemma and asso
ciates3 found that coronary artery disease
was more severe in patients who suffered an
infarct than in those who did not. Flemma3
also noted a greater number of patients with

_
/P <
\X 2 =

0.005
8.02

poor left ventricular function in those with
PMI.
In the past, it was postulated that the in
cidence of PMI may be attributable to car
diopulmonary bypass alone. In one study of
noncoronary artery heart surgery there was
a 7% incidence of acute myocardial infarc
tion.11 However, in our study, after subject
ing the factors involved in cardiopulmonary
bypass to thorough analysis, including per
fusion pressure and perfusion time, we were
unable to demonstrate any significant dif
ference between the infarct and the nonin
farct groups. One difference between the
study of Hultgren and associates11 and our
own is the use of total body hypothermia
to 30°C as part of their cardiopulmonary
bypass technique; our patients were normothermic. Rose and colleagues0 used hypo
thermia; they found no correlation in the
incidence of infarction with hypothermia or
the use of cross-clamping of the aorta during
surgery. Flemma and associates3 had the re
verse experience. In our experience, the
number of grafts has not influenced the in
cidence of PMI; these results agree with
those of others.1' :i' 5
Of special interest in our intraoperative
data is the role of endarterectomy. Our stu
dy seems to indicate that endarterectomy is
of some predictive value; an endarterectomy
doubles the patient’s chance of a PMI. At
times, however, endarterectomy provides
the only means of extending the operability
of a diffusely involved right coronary artery
and such salvage may well be worth the
risk.13' 16
Our postoperative data on the increased
incidence of ventricular arrhythmias and
mortality rate agree with data from other
centres.1 2 8 Ventricular arrhythmia has
little predictive value; this complication is
most likely secondary to the infarction ra
ther than the primary event.
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The mortality in the infarct group was
related to the condition of the myocardium.
One patient sustained a cardiac arrest follow
ing the induction of anesthesia. He was re
suscitated, but at operation and postoperatively there was evidence of a massive myo
cardial infarction. In another patient, who
preoperatively had unstable angina, ventri
cular tachycardia and fibrillation developed
48 hours postoperatively. At autopsy both
grafts were thrombosed even though good
graft flow rates were obtained at operation.

5.

6.

7.

8.
9.

C onclusion

Patients with postoperative myocardial in
farction after CAB surgery have a higher in
cidence of ventricular arrhythmias than
those with no infarction. Among factors con
sidered preoperatively, intraoperatively and
postoperatively, only endarterectomy ap
pears to contribute significantly to the inci
dence of PMI.
We are indebted to Drs. G. White and G. Taichman and to Mrs. M. Rosenbloom for their valu
able assistance in the preparation of the statis
tical analysis.
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CONTRAINDICATIONS: Hypersensitivity to the cephalosporin group of antibiotics.
WARNINGS: There is evidence of partial cross-allergenicity between the penicillins and
the cephalosporins. Therefore, cephradine should be used with caution in patients with
known hypersensitivity to penicillins.
Antibiotics, including cephradine. should be used cautiously and only when absolutely
necessary in patients with a history of allergies, particularly to drugs.
Usage during pregnancy and lactation:
Safety for use of this product during pregnancy has not been established. Cephradine
is secreted in breast milk.
PRECAUTIONS: Patients should be observed carefully during therapy Allergic reactions
require discontinuation of VELOSEF and appropriate treatment
Prolonged use of VELOSEF may result in overgrowth of non-susceptible organisms:
appropriate measures should be instituted.
During long-term therapy, hematology, renal and hepatic functions should be monitored
periodically. Patients with known or suspected renal impairment should be observed
carefully since cephradine may accumulate in the serum and tissues unless dosage is
suitably reduced. See DOSAGE AND ADMINISTRATION section
Indicated surgical procedures should be performed in conjunction with antibiotic therapy;
e.g., the incision and drainage of abscesses. After treatment with cephalosporins, a
false-positive reaction for glucose in the urine may occur, but not with enzyme-based tests.
A false-positive Coombs' test has also been reported.
VELOSEF for Injection is physically compatible with most commonly used intravenous
fluids and electrolyte solutions (e g. Dextrose Injection, Sodium Chloride Injection or
M /6 Sodium Lactate). However, it is not compatible with Lactated Ringer's Solution or
other calcium-containing infusion fluids.
ADVERSE REACTIONS: Usually limited to gastrointestinal disturbances and occasional
hypersensitivity, but may include hematological and hepatobiliary disturbances, as well
as elevated BUN, LDH and serum creatinine, superinfection, vaginitis and joint pains
Throm bophlebitis following I V. injection and sterile abscesses after I.M. injection
have occurred.
Only occasionally have adverse reactions been severe enough to warrant cessation
of therapy.
DOSAGE AND ADMINISTRATION: The presence of food in the gastrointestinal tract
delays absorption and reduces the peak serum level but does not affect the total
amount of cephradine absorbed.
VELOSEF Capsules and VELOSEF for Oral Suspension.
Adults: Respiratory tract infections. 250 mg, q6h or 500 mg q12h. Pneumococcal lobar
pneumonia: 500 mg, q6h or 1 g q12h.
Genitourinary tract infections: 500 mg, q6h or 1 g q12h. Prolonged therapy is advisable
for the treatment of prostatitis and epididymitis.
Skin or soft tissue infections: 250 mg q6h or 500 mg q12h.
Children: 25 to 50 m g/kg/day, in two or four equally divided and spaced doses, e g :
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or 1 to 2 tsp. q 12h
1 to 2 tsp. q6h
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or 2 to 4 tsp. q12h
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H. influenzae, doses from 75 to 100 m g/kg/day are recommended. Maximum daily dose
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VELOSEF for Injection: For use in moderate, severe or life threatening infections or where
oral therapy is not possible. Adult daily dose range is 2 - 4 g, depending on the infection.
In children, a daily dose of 50 - 100 m g/kg is recommended.
All patients; all formulations:
Larger doses (up to 1 g q6h in adults or up to 25 m g/kg q6h in children) may be given for
severe or chronic infections: maximum daily dose should not exceed 4 g. Therapy should
be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or
evidence of bacterial eradication has been obtained. In infections caused by hemolytic
streptococci, a minimum 10-day-treatment period is recommended. Stubborn infections
may require treatment for several weeks with frequent bacteriological and clinical appraisal.
A modified dosage schedule in patients with decreased renal function is necessary
Each patient should be considered individually: the following schedule is recommended
as a guideline. Initial loading dose: 750 mg. Maintenance dose: 500 mg at the time
intervals listed below:
Creatinine Clearance
(ml/min/1.73m2)
> 20 ml/m in
15-19 ml/m in
10-14 ml/m in
5-9 ml/min
< 5 ml/m in

Time Interval

6-12

1 2 -2 4
24 - 40
40 - 5 0
5 0 - 70

hours
hours
hours
hours
hours

DOSAGE FORMS: Capsules of 250 mg and 500 mg in bottles of 50, and bottles of
VELOSEF 125 and 250 for Oral Suspension which, after reconstitution, provide 100 ml of
a pleasantly flavoured suspension containing 25 m g/m l and 50 m g/m l respectively.
VELOSEF for Injection is provided as a sterile powder for reconstitution in vials containing
500 mg or 1.0 g Consult Product Monograph or Package insert for reconstitution procedure.
Product Monograph available to physicians and pharmacists on request
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Aortographic search jo r ruptured thoracic aor
ta (R T A ) should be done only in those trauma
patients with radiographic evidence o j a widen
ed mediastinum. Turney and colleagues (J Thorac Cardiovasc Surg 72: 727, 1976) reviewed
the combined experience o f two medical cen
tres with R T A ; their study was based on a
5-year experience with 31 cases.
Twenty-five o f the 31 patients (8 1 % ) sur
vived. The mean age was 26 years (range, 15
to 67); most were operated on within 18 hours
after injury. Serious nonthoracic injuries
were present in every case. Surgical repair was
done with a left heart bypass in 2 cases (1
death), a passive aorta-to-aorta shunt in 23
cases (5 deaths) and without shunt or bypass in
6 cases (no deaths). In all but one case an endto-end Dacron graft was used in the recon
struction. Paraplegia developed in 1 patient,
renal failure in 3 patients (2 deaths), transient
hypertension in 18 (7 2 % ) o f the survivors and
palsy o f the left recurrent laryngeal (R L ) nerve
in 8 (3 2 % ) o f the survivors. Two deaths could
be attributed to technical problems with the
shunt; two to intrapleural exsanguination. C om 
plications and blood loss were lowest in those
with no shunt; where possible this is the proce
dure o f choice.
The mediastinum was clearly widened on
the anteroposterior chest radiographs in most
cases and definition o f the aortic knob was
blurred in all. M a jor associated thoracic injury
was present in all cases. Hypotension due to
bleeding was present on admission in eight
cases; in all o f these, transfusion and general
supportive measures permitted aortographic
studies before thoracotomy. Six patients
with evidence o f intraperitoneal bleeding
underwent laparotomy first. These patients
were all found to have, among other injuries,
a ruptured spleen; thoracotomy followed lapa
rotomy and five o f the six survived. Four others
with questionable intra-abdominal bleeding had
a laparotomy after the thoracotomy; none of
these had a ruptured spleen and all survived. In
no case was the vagus or R L nerve severed by
the surgeon, although much manipulation o f
the R L nerve was often required.
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EXPERIENCE WITH REOPERATION FOLLOWING CORONARY
BYPASS GRAFTING*
W. J. KEON, MD, FRCSfC], P. BEDARD, MD, FRCS[C], Y. AKYUREKLI, MD, FRCS[C]
and M. BRAIS, MD, FRCSfC]
Thirty-four of 1152 patients who had undergone
aortocoronary bypass grafting underwent re
operation. There were no early or late deaths
among these 34 patients. The average time be
tween operations was 14 months. At the initial
operation, 88 grafts and 10 internal mammary
implants were placed; at reoperation, 56 grafts
and 8 internal mammary implants were placed
and a left ventricular aneurysm was plicated.
Twenty patients underwent reoperation for graft
stenosis or occlusion, five because of progres
sion of coronary artery disease, seven because
of combined progression of disease and graft oc
clusion and two to correct technical errors. Im
provement in the class of angina was 1.1 classes
at an average follow-up of 9 months. The authors
believe that reoperation for coronary bypass
grafting can be performed safely with symptoma
tic improvement for the patient.
Trente-quatre patients sur 1152 qui ont repu un
pontage aortocoronarien, ont subit une nouvelle
intervention. II n'y a eu aucun deces precoce ou
retarde chez ces 34 patients. L'intervalle moyen
entre les operations a ete de 14 mois. A la pre
miere operation, on avait realise 88 pontages et
place 10 greffons mammaires internes; lors de
la seconde intervention, 56 pontages et 8 gref
fons mammaires internes ont ete mis en place,
et un anevrisme ventriculaire gauche a ete re
pare. Vingt patients ont ete reoperes a cause de
I'occlusion ou de la stenose d'un greffon, cinq
a cause de 1'evolution de la maladie coronarienne, sept a cause, a la fois, de 1'evolution de la
maladie et de I'occlusion du greffon et deux pour
corriger des erreurs techniques. Apres une periode moyenne de post-observation de 9 mois, on
a observe une amelioration de 1.1 classe dans la
classification de I'angine. Les auteurs croient
qu'une deuxieme operation de pontage coronarien peut etre realisee avec securite et entrainer
une amelioration des symptomes chez le patient.

*From the University of Ottawa cardiac unit,
Ottawa, Ont.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Edmonton, Alta., Oct. 1823, 1976.
Reprint requests to: Dr. W. J. Keon, University
of Ottawa cardiac unit, Ottawa Civic Hospital,
1053 Carling Ave., Ottawa, Ont. K1Y 4E9.

vein bypass grafting was first
performed nearly 10 years ago. In the inter
vening years it has become the most widely
used myocardial revascularization procedure.
It has been termed a successful procedure by
many on the basis of its usefulness in the
relief of angina. Complete absence of angina
has been reported in 79 and 82% of pa
tients operated upon.1 - Reported failure of
aortocoronary bypass grafting requiring re
operation has been rare. In 1972 Adam and
colleagues:! reported on 19 patients requiring
reoperation; 17 survived. In the same year
Johnson and associates4 reviewed 39 cases;
most of their patients had had mammary im
plants previously. In this group there were
four deaths at the time of reoperation and
three late deaths. Skow and associates3 re
ported 14 reoperations; 6 followed a pre
vious vein graft bypass. There was one late
death. Recently, the Stanford Medical Cen
ter reviewed 21 reoperations in which 13
patients obtained relief or improvement of
angina and 1 patient died late.6
We have studied 34 patients who under
went a second coronary artery bypass graft
operation in our unit. There were no early
or late deaths. The indications for operation,
the success rate in the relief of angina and
the technical problems of surgery are dis
cussed.
Saph en o u s

C l in ic a l M a t e r ia l , M e t h o d s a n d
R esults

Thirty-four men underwent a second co
ronary artery bypass graft operation an aver
age of 14 months after the first. In all, the
first operation consisted of bypass grafting
and was performed by the same surgeon who
performed the second. The patients’ average
age was 46 years. At the first operation, normothermic high-flow perfusion was used;
four patients did not require perfusion at the
time of the second operation.
Two of the 34 patients had one diseased
vessel prior to the initial operation, 14 had
two and 18 three diseased vessels. Fourteen
patients had normal ventricular function at
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the first operation, 2 had class I, 15 had
class II and 2 had class III function (Amer
ican Heart Association classification). None
of the patients had congestive heart failure
nor did it occur in the interval between first
and second operation. Before the initial oper
ation, 3 patients were asymptomatic, 9 had
class II angina, 10 had class III, and 12 had
class IV (New York Heart Association
[NYHA] classification) (Table I).
First Operation
Eighty-eight coronary artery bypass grafts
and 10 internal mammary artery implants
were placed (Table II). Seven were single
grafts, 10 were double, 9 triple, 6 quadruple,
and 2 quintuple grafts. The average graft
flow was 62.9 ml/min (range 20-200 m l/
min).
Interval Between Operations
Angiography that led to a second opera
tion was performed in 22 patients because of
angina; in 12 it was part of a routine follow
up. Twenty patients underwent reoperation
for occluded or severely stenosed grafts, five
for progression of coronary disease, seven
for combined graft occlusion and progres
sion of disease, and two for a technical error
TABLE I.—Severity of Angina (NYHA
C lassification)
Class
I

Time
Before first operation......... .
Before second operation. .
After second operation. . . . . .

3
9
25

II

III

IV

9
7
4

10
10
4

12
8
1
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made at the first operation (Table III, Figs. 1
to 4). In one case, the distal anastomosis of
a circumflex graft was inadvertently made
above the area of stenosis; in another patient,
the anatomy was mistaken, and two diagonal
grafts were performed instead of two margi
nal grafts. It was found that 45 of the 88
grafts originally placed in these 34 patients
had occluded.
Prior to the second operation, nine pa
tients had no angina. These patients were
demonstrated at routine follow-up angio
graphy to have defective operations leaving
them at risk for serious infarction and death.
Seven had class II, 10 class III, and 8 class
IV angina (Table I). In patients who were
symptomatic, angina had returned an aver
age of 8 V2 months after the first operation.
Three patients had suffered myocardial in
farction (one had had two) prior to the sec
ond operation. For five patients, ventricular
function was considered to be one class
worse, while for one it was one class better,
before reoperation.
Second Operation
The second operation was performed an
average of 14 months after the first. In pa
tients undergoing reoperation for a technical
error, the average time interval was only 1
month, for patients with occluded grafts it
was 8.7 months, for those with progression
of their disease it was 24.6 months and for
those with a progression of their disease and
graft occlusion it was 27.2 months.
In one operation, no new revascularization

TABLE II.—P rocedures
Operation
Procedure

First

Second

88
10

56
8

0

1

Bypass g raft..............................
Mammary im plant...................
Plication of left ventricular
aneurysm................................
TABLE III.—R eason

for

R eoperation

Reason
Grafts occluded or severely stenosed
Progression of disease........................
Occlusion and progression of disease
Technical error....................................

No. of
patients
20
5
7

2

Fig. 1.—Angiogram showing progressive occlu
sion of a bypass graft, early (A) and late (B).
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was performed. This patient had a localized
occlusion at the distal anastomosis through
which a probe was passed easily, restoring
good graft flow (75 ml/min). In another man
with anterior descending graft occlusion, the
saphenous vein was found to be severely
diseased and a mammary artery to anterior
descending artery anastomosis was per
formed. In four patients, a new graft was not
placed but instead the previous graft, now
occluded, was resected with a new piece of
vein bypassing the stenosed section. In an
other case an arteriotomy was performed
followed by a vein angioplasty. Ten of 45
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occluded grafts were excised during opera
tion while the remainder were left in place.
No grafts were replaced in exactly the same
position; most were anastomosed a few milli
metres distal to the previous anastomosis.
One patient required intra-aortic balloon
pumping for 24 hours after operation.
During the second operation, 56 grafts
were inserted and 8 internal mammary im
plants were placed. In one patient a left
ventricular aneurysm was plicated (Table
II). The average graft flow was 56.1 ml/min.
The graft flow was highest (72.1 ml/min)
in patients who had combined occlusion and
disease and lowest in those who had a tech
nical error (30 ml/min). The flow for those
who had progression of disease alone was
53.6 ml/min and in patients with occluded
grafts it was 50.1 ml/min.
Follow-Up

Follow-up information on all patients was
obtained at a mean time of 9 months after
operation. Twenty-five patients had no
symptoms of angina, 4 had class II, 4 class
III, and 1 remained in class IV (Table I).
Since, prior to the second operation, none
were worse, five patients had therefore im
proved by three classes and seven by two
classes. Sixteen patients who had received
19 grafts at reoperation underwent follow-up

B
Fig. 2.—Angiogram showing progression of coronary disease since first operation. (A) Preoperative
angiogram, (B) 3 weeks after operation and (C) 23 months after operation.
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angiography; 4 of the grafts were occluded.
Stress tests performed on these 16 patients
were positive for myocardial ischemia in
three instances.
D iscussion

In our clinic, either operative failure or
progression of disease as evidenced by angio
graphic assessment (at routine follow-up
examination or for severe angina) is an indi
cation for reoperation. Reoperation is recom
mended when surgically correctable prob
lems such as graft occlusion or progression
of disease are demonstrated.
Our findings concerning symptomatic im
provement differ from those of Winkle and
associates.0 Winkle’s group could not de
monstrate much improvement in angina fol
lowing reoperation; this was particularly ap
parent in patients with occluded grafts.0 We
found that after reoperation patients im
proved an average of 0.41 classes in the in
terval between the first and second opera
tions and had improved 1.1 classes between
the time of reoperation and follow-up. The
greatest improvement was in patients with
progression of disease who improved 2.0
classes, while those with graft occlusion im
proved 1.0 class. There was a lesser degree
of improvement in the other groups — 0.7

Fig. 3.—Angiogram showing combined graft oc

clusion (A) and progression of coronary artery
disease (B).
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classes in patients with graft occlusion and
progression of disease and 0.5 in those in
whom there was a technical error at the ini
tial operation.
We agree with those authors3-6 who be
lieve that there are many more technical
problems associated with reoperation. How
ever, we do not find the difficulties insur
mountable and we have not had the severe
problems that Johnson and his colleagues4
encountered when two of their patients died
at operation. In one of our patients, a func
tioning graft was divided when the chest was
opened, but it was reanastomosed and the
operation successfully completed. Adam and
colleagues8 found that the time spent on by
pass during the second operation was longer
than at the first; this differs from our experi
ence. Perfusion time averaged in our series
68.66 minutes originally and 61.56 minutes
at reoperation (this excludes the four patients
who did not require cardiopulmonary bypass
at reoperation).
In 27 of our 34 patients grafts became
occluded after the initial operation; 45 of
the 88 originally placed grafts became oc-

Fig. 4.—Angiogram of patient in whom tech
nical error was made at first operation. Graft
placed proximal to area of stenosis marked by
arrow.
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eluded. This is a much lower percentage
than that reported by Adam and colleagues
and Winkle and associates.'1 This may be
the result of our attempt to place a graft
even in technically difficult cases. In addi
tion we do not consider an operation com
plete unless moderately as well as seriously
stenosed vessels have been bypassed. One
half of patients in our series had triple,
quadruple, or quintuple grafts. It appears
that when graft occlusion occurs it does so
just after operation since the interval be
tween operations for the patients with oc
cluded grafts was only 8.7 months. A sur
prising finding was that the blood flow
through those grafts that were found on
follow-up angiography to be occluded
averaged 63 ml/min at first operation
(range, 30 to 150 ml/min). We believe
therefore that low flows at operation are not
necessarily indicative of future graft occlu
sion.
Thirty-five percent (12 of 34) of patients
undergoing reoperation received their first
operation on an emergency basis. Nine pa
tients had preinfarction angina and three had
acute unstable myocardial infarction. Two
patients were classified as being emergencies
at second operation; both had preinfarction
angina. Emergency operations are obviously
performed under greater pressure than elec
tive operations; in some cases the only ob
jective at the time of the emergency surgery
is to keep the patient alive, but where pos
sible complete revascularization should be
attempted.
Of our 1186 patients 319 received routine
follow-up angiography at the National De
fence Medical Centre in Ottawa. Routine
angiography appears to be valuable in deter
mining which patients require reoperation;
the risk of late death is thereby lowered.
Those who underwent routine follow-up
angiography had a 5 % (16 of 319) reoper
ation rate and 0.9% (3 of 319) late mortality
rate compared with 2% (18 of 867) reoper
ation and 7.7% (67 of 867) late mortality
rate in those who did not receive routine
follow-up angiography.
The major dilemma with routine follow-up
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angiography is that some asymptomatic pa
tients will have evidence of a defective oper
ation; this leaves them at serious risk for in
farction and death. We have reoperated on
these patients in an attempt to diminish
these risks. We also believe that an adequate
assessment of the effect of this operation’s
late mortality cannot be made unless the
operation is satisfactory from a technical
point of view. The criteria necessary to de
fine a satisfactory technical operation for
complete revascularization will require fur
ther study.
C o n clu sio n

In patients with coronary artery disease,
reduction in symptoms can be obtained by
reoperation. Although reoperation is tech
nically more difficult than the initial opera
tion it can be performed successfully without
undue risk. Routine follow-up angiography
is valuable in assessing the results of sur
gery and leads to early diagnosis of inade
quacies resulting from the first operation. A
second operation is not unduly delayed and
late mortality decreases. Patients who have
angiographic evidence of graft malfunction
or progression of disease deserve a second
operation.
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ACTINOMYCOSIS OF THE GALLBLADDER*
THOMAS MARRIE, MD, H. GRANT STIVER, MD, FRCP[C], ANDRE MOLGAT, MD,
FRCS[C], ROBERT G. STARK, MD, MRCPath, FRCP[C] and DOUGLAS NORRIS, MSc
Actinomycosis of the gallbladder is rare, and
the pathogenesis of the infection is poorly un
derstood. The authors report the case of a 77year-old man admitted to hospital because of
abdominal pain. Clinical and laboratory findings
suggested the diagnosis of cholecystitis and cho
lelithiasis. At cholecystectomy the gallbladder
was inflamed and contained many calculi. Gram
staining of material from the mucosa of the
gallbladder demonstrated gram-positive pleomor
phic filaments, and A ctinom yces isra e lii grew in
pure culture, thus confirming the diagnosis of ac
tinomycosis of the gallbladder. The pathogenesis
of the condition is also discussed.
L'actinomycose de la vesicule biliaire est une
infection rare dont la pathogenese est mal connue. Les auteurs signalent le cas d’un homme de
77 ans, hospitalise pour douleurs abdominales.
Les examens cliniques et de laboratoires indiquaient un diagnostic de cholecystite et de cholelithiase. Au moment de la cholecystectomie, la
vesicule etait enflammee et contenait plusieurs
calculs. La coloration gram des prelevements de
la muqueuse de la vesicule a revele des fila
ments pleomorphes gram positif, et de I'A c tin o 
myces is ra e lii a pousse en culture pure, confirmant ainsi le diagnostic d'actinomycose de la
vesicule biliaire. La pathogenese de cette affec
tion est aussi discutee.

*From the departments of medicine, surgery and
pathology, St. Boniface General Hospital, Winni
peg, Man.
Reprint requests to: Dr. Thomas Marrie, Depart
ment of medical microbiology, Health Sciences
Centre, 700 William Ave., Winnipeg, Man. R3E
0Z3.

A b d o m in a l actinomycosis, caused by infec
tion with Actinomyces israelii, usually re
sults from damage to the gastrointestinal
mucosa and often rupture of the gastrointes
tinal tract. Secondary spread within the ab
domen is usually to the abdominal wall,
retroperitoneum, subphrenic space and oc
casionally the liver,1 but actinomycosis of
the gallbladder is extremely rare;- Davies
and Keddie:i reported a probable case of
actinomycosis of the gallbladder and were
able to find only two other established cases
described in the literature. We report such
a case to draw attention to this rare condi
tion and to discuss its pathogenesis, which
is poorly understood.
C ase R e po r t

A 77-year-old man with an unremarkable
medical history was admitted to hospital com
plaining of severe epigastric pain associated
with nausea and vomiting. There were no iden
tifiable precipitating factors. He had experi
enced similar bouts of pain in the past but
could not remember when such an episode had
last occurred.
On physical examination he appeared to be
in moderate distress; the epigastrium and right
upper quadrant were tender on palpation and
his oral temperature was 37.5°C. Nasogastric
suction and intravenous therapy were instituted.
Initial laboratory data included a leukocyte
count of 12.6 x 107/ and a serum amylase
concentration of 2100 Somogyi units/dl. The
results of other laboratory investigations over
the next few days are shown in Table I. Intra
venous cholangiography was carried out 10
days after admission. Lucencies in the com-

TABLE I.— L aboratory I nvestigations
Serum concentration (normal range)
Day
1

2
.
3 . . .. . .'.........
5
7 ...........
i o : .

(

Amylase
Alkaline
50-150 Somogyi phosphatase
units/dl)
(30-125 IU /l)
2100

600
50
—
-

520
288
271
182
172

Total
bilirubin
(0.2-1.0 mg/dl)
_

0.9
1.2
0.6
0.5
0.3

(

Lactic
dehydrogenase
100-125 IU /l)
_

238
125
127
212
137

Glutamic
oxaloacetic
transaminase
(14-47 IU /l)
_

405
81
35
21
37
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mon bile duct were interpreted as calculi. At
cholecystectomy the gallbladder was found
to be grossly inflamed, and to contain con
taining many large calculi; a large calculus
was found in the common bile duct. Postoperatively penicillin G (20 million units daily)
was given intravenously for 6 weeks, followed
by tetracycline (2 g daily) orally for 4 months.
Pathology
The gallbladder (length, 8 cm; diameter, 3
cm) contained many multifaceted calculi and
areas of hemorrhagic mucosa. Microscopic
examination disclosed areas of mucosal loss
with replacement by granulation tissue. Within
the wall there were aggregations of lympho
cytes and plasma cells more numerous than is
usual in chronic cholecystitis due solely to
calculi; in areas of the mucosa, foci of typical
actinomycotic granules were present (Fig. 1).
Microbiology
Swabs taken from the gallbladder mucosa at
operation were inoculated into thioglycolate
broth and cooked meat media, and incubated
at 37°C. In 7 days colonies that varied in size
from pinpoint to large lobulated forms were
seen. These grew to within 2 cm of the surface
of the broth. Microscopic examination revealed
gram-positive pleomorphic filaments with
and without branching (Fig. 2). Biochemically
the organism was catalasenegative and pro
duced acid but no gas from glucose, xylose,
mannose and raffinose; there was no reaction
to mannitol, no liquefaction of gelatin and no
reduction of nitrate. These biochemical char
acteristics identified it as A. israelii.4 No Actinobacillus actinomycetemcomitans was re
covered.

Fig. 1.—Mucosal involvement of gallbladder by

actinomycotic granule (Gram’s stain, reduced bv
49% from x 25).
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D iscussion
A. israelii, the causative agent of actino
mycosis, is gram positive, nonsporulating,
anaerobic or microaerophilic and is fre
quently found in the human mouth and in
gastric aspirates. "’ The presence of hyphae
with true branching suggests that the organ
ism is a fungus, but the lack of sterols in the
cell wall, the sensitivity to antibacterial anti
biotics and its anaerobic requirements are
bacterial properties.6
Clinically, actinomycosis involves three
main anatomical regions. Cope’s classic
monograph7 reported cervicofacial lesions
in 63% of 1330 patients, thoracic disease
in 15% and abdominal involvement in 22%.
Weese and Smith8 in a review of 57 cases
of actinomycosis noted a similar distribution
among these three anatomical regions.
In abdominal actinomycosis spread of the
infection is usually contiguous rather than
by the lymphatic or hematogenous route, but
metastatic spread may occur.9 The usual
sites of secondary spread within the abdo
men are to the abdominal wall with the
formation of multiple draining sinuses, to the
retroperitoneal region, the subphrenic space
and occasionally to the liver.- The liver is
the most common solid abdominal site of
actinomycosis and seeding of the liver in
some instances may occur through the portal
vein;19 gallbladder involvement is rare. Ac
cording to Mayo-Robson11 gallbladder in
fection occurs by retrograde spread of Acti
nomyces sp. up the bile duct from the duo
denum, but, if so, more cases of actinomy-

Fig. 2.—Material from swab from gallbladder
mucosa showing gram-positive branching fila
ments (Gram’s stain, reduced by 44% from x
1000).
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cosis of the gallbladder should occur. In our
patient the diagnosis was made fortuitously
when gram staining of a swab of the mucosal
surface of the gallbladder revealed the typi
cal actinomycotic organisms; no features in
the history or intraoperative findings sug
gested the diagnosis. The presence of actino
mycotic granules in the mucosa indicated
invasive disease and not colonization. Inva
sion of the gallbladder wall may have fol
lowed mucosal damage by the cholecystitis.
All strains of A . israelii isolated at the
Mayo Clinic have been inhibited by penicil
lin G at 0.1 jig/m l.9 The recommended
dosage of penicillin for the treatment of ac
tinomycosis varies from 1 million units dai
ly9 to “massive long-term administration” .1
The avascularity and induration that result
following infection with this organism em
phasize the need for lengthy high-dosage
antibiotic administration. Treatment with
penicillin G parenterally followed by tetra
cycline (500 mg qid) for 8 to 12 weeks
should be effective in most cases.9 In our
patient excision of the gallbladder may have
been sufficient; however, because of the
possibility of spread to the liver or to the
mesentery a 6-week course of penicillin in
travenously followed by 4 months of tetra
cycline orally was given. Other organisms,
especially A. actinomycetemcomitans, are
frequently isolated together with A. israe
lii.1'2 The need for treatment directed to
these other bacteria is controversial. Gram
negative organisms (including Pseudomonas
sp., Proteus sp. and Escherichia coli) that
are resistant to penicillin in vitro, tend to be
eradicated in vivo with that antibiotic alone,
as emphasized by clinical cures in patients
treated with penicillin alone.8
As illustrated by this case, actinomycosis

149

of the gallbladder may not be recognized
clinically, especially if mucosal injury by
cholelithiasis is necessary for invasion by
this saprophytic organism. However, the
distinctive histology readily suggests the
diagnosis. Treatment should consist of pa
renteral administration of penicillin followed
by tetracycline orally.
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ACTINOMYCOSIS OF THE COLON*
A. W. JAMES, MD, FRCP[C] and A. H. PHELPS, MD, FRCS[C], FACS
A 44-year-old woman with severe pain in the
right upper quadrant, simulating acute cholecys
titis, was found to have a large tumour in the
transverse colon. Cultures from the mass grew
Actinomyces israelii. Actinomycosis may often
be missed; involvement of the large bowel is
not confined to the appendiceal and cecal areas
and may simulate other intra-abdominal condi
tions.
line importante tumeur du colon transverse a ete
retrouvee chez une femme de 44 ans se plaignant
d’une douleur intense dans le quadrant superieur droit, ressemblant a une attaque de cholecystite aigue. La culture de cette masse tumorale a mis en evidence de I'Actinomyces israelii.
Le diagnostic d’actinomycose peut souvent etre
manque; I'atteinte du gros intestin ne se limite
pas aux regions de I'appendice et du caecum et
peut ressembler a d'autres affections intra-abdominales.

A bdominal actinomycosis, most frequently
found in the liver and ileocecal region, is
often mistaken for appendicitis, carcinoma
of the cecum, tuberculosis or amebiasis. Pri
mary infection elsewhere in the gastrointes
tinal tract is rare. Two cases of primary ac
tinomycotic infection of the colon and rec
tum were reported by Udagawa, Portin and
Bernhoft in 1974;1 in one, the descending
colon was affected with retroperitoneal ex
tension resembling tuberculosis of the spine,
diverticular abscess or primary retroperito
neal malignant neoplasm. We report a case
because it simulated acute cholecystitis
though it was the transverse colon that was
affected.

ance. Her past medical history was unremark
able.
Physical examination showed a slight malar
flush; her temperature was 37°C; pulse rate,
72 beats/min; blood pressure, 120/80 mm Hg;
and weight, 67.5 kg. Heart sounds and electro
cardiogram were normal. She was not jaun
diced. There was a right upper quadrant mass
consistent with large tender gallbladder and
guarding. Oral cholecystography showed only
faint visualization of the gallbladder. Labora
tory investigations were unremarkable (hemo
globin concentration, 13g/dl; hematocrit,
40%; leukocyte count, 11.5X109//).
At laparotomy a large mass was found in the
right transverse colon; it simulated a perfor
ated carcinoma. There was no other abdominal
abnormality. A colostomy and Mikulicz re
section were carried out; the length of the re
sected segment of bowel was 16 cm and the
large mass on the serosal surface measured 10
x 7 cm. The mucosa of the bowel appeared
normal'(Figs. 1 and 2). The tumour was cov-

Fig. 1.—Resected specimen of transverse colon
showing serosal mass.

C ase R eport
A 44-year-old Caucasian woman was ad
mitted for investigation of severe abdominal
pain in the right upper quadrant that had
started suddenly the previous night. The pain
was persistent, sharp and localized; it did not
radiate to the shoulder or back or change on
respiration. There was no nausea or vomiting.
The patient denied a history of food intoler*From the departments of pathology and surgery,
Chilliwack General Hospital, Chilliwack, BC.
Reprint requests to: Dr. A. W. James, Chilli
wack General Hospital, Chilliwack, BC B2P 1P7.

Fig. 2.—Resected specimen of transverse colon
showing apparently normal mucosa.
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ered with a creamy purulent exudate and on
section showed a large cavity filled with green-
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ish pus and granular material. Histologic sec
tions revealed the typical sulfur granules of
actinomycosis, reactive and purulent granula
tion and microabscesses (Figs. 3 to 5). The
bacteriologic cultures taken from the mass
grew, under anaerobic conditions, gram-posi
tive nonsporulating organisms with sulfur gra
nules, identified and confirmed by the refer
ence laboratory of the British Columbia H ealth
Services as Actinomyces israelii. The patient
was treated with ampicillin, did well and was
discharged 12 days after operation. The colo
stomy was closed 1 month later without inci
dent.
Co m m e n t

Fig. 3.—Histologic section of tumour: no evidence
of trauma or disease (hematoxylin and eosin re
duced by 33% from x 80).

Fig. 4. —Section of tumour showing sulfur gra
nule and abscess (hematoxylin and eosin, reduced
by 33% from x 80).

A. israelii is a common saphrophyte in
the human gastrointestinal tract. The mech
anism causing its conversion to a pathogen
is not understood.2' 3 It appears incapable
of penetrating the normal mucosa. Infec
tion usually follows a break in the mu
cosal barrier resulting from disease or trau
ma. In the present case there was no evidence
of pre-existing disease, trauma, infection, or
a gastrointestinal lesion. Gram-positive
branching rods morphologically similar to
Actinomyces sp. were cultivated from the
tonsillar crypts of the patient following lapa
rotomy.
The diagnosis of actinomycosis may be
difficult both clinically and at laparotomy,
and clinical awareness of the possibility of
the condition is necessary so that appropriate
cultures can be mounted under anaerobic or
microaerophilic conditions. The present case
demonstrates that actinomycosis may often
be missed in humans. The serologic diag
nosis of actinomycosis using the method of
crossed immunoelectrophoresis, as proposed
by Holmberg, Nord and Wadstrom,4 would
be a useful adjunct in the diagnosis.
R efer e n c e s

Fig. 5.—Higher magnification of Fig. 4 show
ing branching mycelial filaments and typical colony
of actinomyces surrounded by leukocytes and
bacteria (hematoxylin and eosin, reduced by 33%
from x 320).
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GIANT OVARIAN CYST IN A DWARF*
STEFAN SEMCHYSHYN, MD, RONALD C. STRICKLER, MD, FRCS[C]
and ALAN H. GERULATH, MD, MS, FRCS[C]
The authors describe a case of giant mucinous
cystadenoma in a dwarf. The cystadenoma
weighed 32 kg, almost half the patient’s normal
weight. Such tumours are rare and are some
times mistaken for ascites. They are usually
benign, but care should be taken to remove them
intact since malignant degeneration of mucinous
cysts occurs in 5 to 15% of cases. Understand
ing of the possible complications allows for a
favourable prognosis.
Les auteurs decrivent un cas de cystadenome
mucineux geant chez une naine. Le cystadenome
pesait 32 kg, soit presque la moitie du poids nor
mal de la patiente. De telles tumeurs sont rares
et elles sont parfois confondues avec une ascite.
Elies sont habituellement benignes, mais on doit
prendre soin de les enlever intactes puisqu'une
degenerescence maligne des kystes mucineux
survient dans 5 a 15% des cas. Une connaissance des complications possibles permet d'envisager un pronostic favorable.

before admission, she noted increasing dyspnea
on exertion and on lying flat, fatigue, diffi
culty in walking and increasing edema of both
legs. She was otherwise asymptomatic. She
lived alone and was self-supporting.
She always had been of small stature (height,
121 cm; weight, 67 kg) and had no body or
head hair. Her parents and siblings were of
normal size and had normal hair distribution.
As a child she had had rickets, but had enjoyed
good health since. Menarche occurred at the
age of 14 years and menopause at the age of
43 years.
On admission (Fig. 1) the diaphragm was
noted to be elevated; air entry to both lungs
was reduced, but she was not short of breath
when sitting at rest. Blood pressure was 140/
70 mm Hg in the upright and supine positions.
The veins of the anterior abdominal wall were
dilated; the abdomen was massively distended,
symmetrical and tense. A fluid thrill was pre
sent; shifting dullness was not demonstrable.
Both legs were edematous up to the groin.

G iant ovarian tumours are now rarely en
countered because ovarian masses are de
tected and removed before they can attain
mammoth proportions. Kehrer,1 in a report
of 100 cases from 1873 to 1928, defined two
criteria for the diagnosis of giant ovarian
cysts: the tumour mass weighs at least 25
kg and the total body weight of the patient
following extirpation approximates the
weight of the cyst. The largest tumour was
described by Spohn and weighed 147.6 kg.2
Reports of these neoplasms have decreased
notably in the last 5 decades; from 1928 to
1975 only 26 cases were documented.1- :!'s
This report describes a case of giant muci
nous cystadenoma in a dwarf.
C ase R epo rt
Clinical Course

A 66-year-old Canadian-born Caucasian
woman had experienced gradually increasing
abdominal girth for 4 years. Over the 3 months
*From the department of obstetrics and gyneco
logy, St. Michael’s Hospital, University of To
ronto, Toronto, Ont.
Reprint requests to: Dr. Alan H. Gerulath, De
partment of obstetrics and gynecology, St. Michael’s
Hospital, 30 Bond St., Toronto, Ont. M5B 1W8.

Fig. 1.—Patient on admission showing massive
symmetrical abdominal distension, dilated super
ficial veins in anterior abdominal wall, dwarfed
stature and alopecia.
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The patient’s hematologic values, urinalysis,
biochemistry values (liver function tests, elec
trolytes, creatinine), blood gases and electro
cardiogram were normal. Chest radiography
confirmed the diaphragmatic elevation and
consequent reduction of lung fields; intraven
ous pyelography suggested an abdominal tu
mour, partially compressing both ureters.
At laparotomy, a smooth, thick-walled cyst,
which arose from the right ovary, filled the
peritoneal cavity. Adhesions between the mass
and the anterior and posterior parietal perito
neum, omentum and bowel were divided by
blunt and sharp dissection leaving raw surfaces
that could not be covered. After insertion of
a trocar, 14 / of fluid was slowly drained from
the mass to permit delivery from the abdomen.
The ovarian cyst was then removed intact fol
lowing closure of the drainage opening with a
purse-string suture. The small uterus and atro
phic left ovary were removed without diffi
culty.
Ascites and dependent edema developed
over the first 3 postoperative days. The se
rum protein concentration, which was 5.5
g/dl (albumin:globulin ratio, 3.8:2.8) preoperatively, decreased to 3.7 g/dl (A:G ratio,
2.7:2.0) by the 3rd day. During the same in
terval, the hemoglobin concentration decreased
to 9.1 g/dl from 11.4 g/dl. For 2 days she was
transfused with albumin (100 g), two units of
whole blood and two units of packed cells.
The ascites and edema rapidly cleared and on
the 7th day the serum protein concentration
was 6.5 g/dl (A:G ratio, 3.7:2.8) and the he
moglobin value, 10.6 g/dl. Her postoperative
course was otherwise uneventful. She was dis
charged on the 9th day and was well when
last seen, 6 weeks after the operation.
Anesthesia
Premedication of atropine was given 1 hour
before operation. Following 5 minutes of oxy
genation, a “crash induction” was undertaken
with thiopentone and succinylcholine. As the
abdominal mass interfered with the handle of
the laryngoscope, intubation could be accom
plished only with the head turned 60° to the
side. Anesthesia was maintained with nitrous
oxide, oxygen 4.2 //min. and halothane 0.5%.
Using manual ventilation a pressure of 48 cm
H20 was required to obtain a tidal volume of
500 ml. After removal of the abdominal tu
mour, 12 cm HsO airway pressure created the
same tidal volume. During drainage of the
cyst, metaraminol bitartrate (Aramine, 1 mg
intravenously) was given to prevent hypoten
sion. Total fluid replacement during the 2-hour
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operation was 1000 ml Ringer’s lactate solu
tion. During the first 24 hours after operation,
the blood gases and biochemical values re
mained in the normal range and there was no
hypotension.
Pathology

The smooth, thick-walled, partially deflated
cystic mass weighed 18 kg; it was multilocular
with solid plaque-like areas on the inner sur
face. Microscopic examination confirmed the
diagnosis of a mucinous cystadenoma. Focal
areas of Brenner tumour were found in the
cyst wall.
D iscussion
The giant cystadenoma weighed approxi
mately 32 kg (weight of fluid plus pathology
specimen) and accounted for 48% of this
woman’s preoperative weight. The huge size
of the tumour could be attributed to patient
neglect as the tumour was benign and the
history of increasing abdominal girth span
ned 4 years. The presentation in a dwarfed
woman made the appearance more dramatic,
but is probably only circumstantial.
Most, but not all, giant ovarian tumours
are benign. The ovarian cyst is commonly
mistaken for ascites; resultant paracentesis
may delay treatment. In malignant ovarian
cysts, paracentesis may result in the spillage
of neoplastic cells into the peritoneal cavity.
This case underlines the necessity for care
ful investigation. The initial impression was
that the patient had an advanced malignant
condition; simple palliative measures would
have been unfortunate.
Histologically, most giant tumours are
mucinous cystadenomas in adults and be
nign cystic teratomas in young women. ’1 The
association of the mucinous and Brenner
elements in the tumour of our patient is not
unexpected, since both elements arise from
the same stem cell.- Every effort should be
made to remove cystadenomas intact. Ma
lignant degeneration of benign mucinous
cysts has been found in 5 to 15% of cases.This possibility and the danger of pseudo
myxoma peritonei should make the physi
cian especially careful to remove cysts intact
without spilling the contents.
Visceral and peritoneal adhesions from
these cysts have been described in the ma
jority of patients; we were able to free these
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with varying degrees of difficulty. Although
not a problem in our patient, partial resec
tion of the cyst wall and, rarely, marsupial
ization of the cyst to the abdominal wall
were required in other cases in which there
were dense adhesions.T he pathogenesis of
the adhesions is unclear; however, they could
result from a foreign-body giant-cell reaction
due to a leakage of fluid, or from subclinical trauma to the cyst wall, such as friction
during respiration with resulting hemorrhage
and necrosis.
The raw peritoneal surface that remained
after the adhesions were resected led to
the loss of blood and protein-rich fluid into
the peritoneal cavity. The resulting fall in
intravascular osmotic pressure further con
tributed to the ascites and dependent edema.
Paracentesis would only aggravate this loss
of serum protein. The administration of in
travenous albumin and whole blood can be
curative as it was in our case.
The edema of the lower limbs and the di
lated superficial veins over the abdomen are
evidence of inferior vena caval compression.
The patient did not demonstrate supine hy
potension, which may occur with large pelvic
tumours and during late pregnancy. When
present, supine hypotension is relieved by
turning the patient into the lateral recum
bent position. In our patient, the long history
may have permitted formation of an ade
quate collateral venous return; postoperatively she did not suffer from chronic su
pine hypotension. This complication may
occur and is presumed to result from ex
tensive pooling of blood in the expanded
venous space.
The difficulty we experienced in intubat
ing our patient was unique but was easily
overcome by a change in her head position.
In the anesthetic management of patients
with giant abdominal tumours adequate ven
tilation pressures must be established to
overcome the compression effect on the
diaphragm and to allow for correction of
any blood-gas or acid-base imbalance. Dur
ing drainage of large masses containing pro
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tein-rich fluid, hypotension may occur; the
prophylactic vasopressor given to this patient
masked or prevented this effect. After sur
gery, the relief of vena caval compression
may result in hypertension due to the sud
den improvement in venous return as hap
pened in our patient. Fluid administration
initiated before operation may over-expand
the vascular volume and also contribute to
postoperative hypertension.6 Our patient had
no problems with blood pressure.
In Canada, where medical care is easily
accessible and surgical intervention for ova
rian masses is prompt, giant ovarian tumours
should be almost unknown. When such
cases are seen it is important to recognize
the benign nature of the lesion, to try and
remove the lesion intact and to understand
the potential complications so that they may
be prevented.
We thank Dr. W. Noble, department of anesthe
siology, for advice in the preparation of this
manuscript and Mrs. S. Sumar for secretarial
assistance.
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METHYSERGIDE THERAPY CAUSING VASCULAR INSUFFICIENCY
OF THE UPPER LIMB*
F. M. AMELI, MB, ChB, FRCS(Edin), FRCS[C], M. NATHANSON, MD, FRCP[C]
and I. ELKAN, MD, FRCP[C]
A 41-year-old woman, who was receiving methysergide maleate for the treatment of severe
headaches, had occlusion of the left brachial
artery, confirmed by arteriography. The occlu
sion was believed to result from the use of methysergide and the drug was therefore with
drawn. Within 4 days the distal pulses were nor
mal, as confirmed by arteriography, and she was
asymptomatic.
Une femme de 41 ans ayant regu du maleate de
methysergide pour le traitement de cephalees
intense, a souffert d'une occlusion de I'artere
brachiale gauche, confirmee a I'arteriographie.
On a cru que I'occlusion pouvait avoir ete causee par le methysergide, et on en cessa done
I'administration. En quatre jours les pouls des
extremites sont devenus normaux, tel que con
tinue a I’arteriographie, et il y a eu disparition
des symptomes.

M ethysergide (1, methyl-d-lysergic acid
butanolamide; Sansert) therapy commonly
causes mild transient side effects, such as
diarrhea, nausea and vomiting. Certain cen
tral nervous system symptoms such as drow
siness, nervousness, insomnia, euphoria, ex
citement and confusion may also occur. We
present the unusual case of a woman who
suffered transient brachial artery occlusion
after receiving methysergide for the treat
ment of vascular headaches.

ages of cigarettes daily. Two months before
coming to the outpatient department methy
sergide bimaleate (2 mg tablets) was pre
scribed by her family physician for treatment
of continuing severe headaches; she took two
to three tablets daily.
On admission to hospital her blood pressure
was 130/70 mm Hg in the right arm; no blood
pressure was obtainable in the left arm. The
left hand was cold and pale and no radial or
ulnar pulses were palpable. The remainder of
the physical examination was unremarkable.
Results of the laboratory investigation were
as follows: hemoglobin value, 13.3 g/dl; ery
throcyte sedimentation rate, 5 m m/h; serum
creatinine value, 2.2 mg/dl; blood urea nitro
gen concentration, 12 mg/dl; serum choleste
rol concentration, 228 mg/dl and serum tri
glyceride concentration, 96 mg/dl. Coagula
tion studies were normal.
An arteriogram showed occlusion of the
left brachial artery just beyond its origin (Fig.
1). There was delayed filling of the radial and

C ase R eport
A 41-year-old white woman was admitted to
hospital from the outpatient department com
plaining of numbness in the left hand. She
had been admitted 2 years before with acute
pyelonephritis and nephropathy following in
gestion of analgesic drugs over a period of 10
years. After discharge, as had been her cus
tom, she continued to take propoxyphene hy
drochloride (Darvon) and to smoke two pack-

*From the departments of surgery, medicine and
radiology, Toronto East General and Orthopaedic
Hospital and the University of Toronto, Toronto,
Ont.
Reprint requests to: Dr. F. M. Ameli, Ste. 9,
900 Coxwell Ave., Toronto, Ont. M4C 3G2.

Fig. 1.—Occlusion of left brachial artery.
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ulnar vessels in the forearm (Fig. 2). These
vessels were in a state of severe spasm.
After review of the radiographs and discus
sion of the patient’s previous drug therapy, it
was concluded that the vascular occlusion could
have resulted from the use of methysergidc.
Accordingly the drug was withdrawn. Within
4 days the distal pulses returned to normal and
the patient became asymptomatic. Codeine was

Fig- 2.—Delayed filling of left brachial radial
and ulnar arteries.
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prescribed after her discharge and she was ad
vised to stop smoking. Repeat arteriography
1 month later showed the vessels in the left arm
to be normal (Fig. 3). The patient has remained
asymptomatic.
D iscussion
Methysergide is a congener of lysergic
acid diethylamide (LSD). It is an ergot
^derivative but has only slight vasocon
strictor and oxytoxic activity. It has been

Fig. 3.—Normal brachial artery after withdrawal
of methysergide.
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for bowel management
and anorectal
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“ Gentle persuasion sums it up!” Metamucil
is a natural source preparation that pro
duces a gentle action.
Metamucil, refined and purified from natu
ral psyllium seed, works gently but firmly.
It does not depend on chemical irritants,
methylcellulose or other synthetic laxative
agents for its effect.
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CHRONIC SUBPHRENIC ABSCESS: THE MISSED DIAGNOSIS*
G. A. C. MILNE, MD, FRCS[C] and I. W. GEERE, MB, ChB, FRCP[C]
This report of a case of chronic subphrenic
abscess, with a brief review and recommenda
tions for diagnosis and prevention, draws atten
tion to this clinical entity as a potential cause of
chronic ill health. The clinical presentation and
laboratory findings in this case were unremark
able. It is clear that the condition can be easily
missed and the patient may be exposed unneces
sarily to prolonged illness and to inappropriate
investigation and therapy.
Ce rapport d'un cas d'abces chronique de la re
gion sous-diaphragmatique, accompagne d’une
breve revue et de recommendations sur son
diagnostic et sa prevention, vise a attirer I'attention sur cette entite clinique comme cause pos
sible d’un etat maladif chronique. Le tableau
clinique et les resultats d’analyses de laboratoire n'offraient rien de particulier. II est evident
que cette affection peut facilement ne pas etre
decelee et le patient peut alors etre inutilement
expose a une maladie prolongee, et a des examens et traitements inadequats.

A lthough reports of a delayed manifesta
tion of subphrenic abscess have appeared in
the literature,1-4 their apparent scarcity sug
gests either that the condition is rare or that
it goes unrecognized and contributes to the
pool of patients with chronic ill health. These
considerations have prompted us to report
a case of subphrenic abscess in a 20-yearold woman who presented with a 6-week
history of chest pain, fever and weight loss
6 months after appendectomy.
C ase R e p o r t

A 20-year-old Caucasian woman (weight,
51.6 kg) had a 6-week history of chest pain,
fever, chills and weight loss (2.25 to 2.7 kg).
The pain, described as dull, dragging, or pull
ing, was present in the right upper chest and
the right posterolateral aspect of the neck; the
patient attributed the neck pain to muscle
strain caused by curling. During the previous
6 weeks the pain had moved to the right lower
chest and was worse on deep breathing. Two
weeks before admission, she had sought med
ical advice elsewhere and, after results of a
chest radiograph were negative, was treated
*From the departments of surgery and pathology,
University of Saskatchewan, Plains Health Centre,
Regina, Sask.
Reprint requests to: Dr. I. W. Geere, Department
of pathology, Plains Health Centre, 4500 Wascana
Parkway, Regina, Sask. S4S 5W9.

for pulmonary embolism, but her condition did
not improve.
On physical examination the patient ap
peared slightly pale and anxious, but not great
ly distressed. The temperature was 37.9°C; for
the next 7 days before effective antibiotic the
rapy was introduced it varied between 37 and
39°C. The patient, a nonsmoker, had a slight,
nonproductive cough, which had been present
for 2 weeks. The only notable physical finding
was diminished air entry in the right lower
chest. A chest radiograph showed moderate
elevation of the right hemidiaphragm and a
small effusion in the right costophrenic angle.
The lung parenchyma was normal. A lung
scan at the time of admission and a liver scan
7 days later were normal. Laboratory findings
showed slight normocytic, normochromic ane
mia (hemoglobin concentration, 10.9 g/dl); the
total leukocyte count was 10.7x10V/ t64%
polymorphs, 25% lymphocytes); the erythro
cyte sedimentation rate was 71 mm/h (Westergren); the alkaline phosphatase concentration
was increased slightly (109 TU/l) as was the se
rum glutamic oxaloacetic transaminase (51
IU//). Other concentrations of serum electro
lytes were normal.
Aspiration of the effusion produced 4 ml
of heavily blood-stained pus, which on gram
staining showed two morphotypes of gram
negative bacteria. Cultures of the material
grew Escherichia coli and Bacteroides jragilis.
This unusual finding in an otherwise active and
healthy young woman prompted a review of
the patient’s medical history, with the emphasis
on possible intra-abdominal sepsis. We learned
that the patient had undergone appendectomy
6 months before for a ruptured appendix; this
was followed by an episode of pneumonia that
had resolved satisfactorily with antibiotic the
rapy. Since then the patient had been normally
active, but had experienced fatigue more
readily.
Antibiotic therapy, which was originally ce
phalexin (500 mg, bid, orally), was changed to
gentamicin (60 mg, lid, IV) and clindamycin
(600 mg, qid, IV); after 48 hours the patient’s
fever resolved. After 4 days clindamycin was
replaced by chloramphenicol (500 mg, qid, IV)
because of the onset of diarrhea.
A liver scan and later a liver-lung scan were
done, because an intra-abdominal abscess —
more specifically a subphrenic collection of
pus — was suspected. These studies disclosed
a defect in the posterior aspect of the right lobe
of the liver; the findings were consistent with
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the presence of a collection of pus. Subsequent
surgical exploration by the Ochsner approach
revealed a posterior subphrenic abscess con
taining approximately 60 ml of pus. The abscess
was drained. From the pus E. coli and B. fragilis were cultured. These organisms were
found to be identical biochemically to the or
ganisms originally isolated from the thorax.
The patient’s subsequent course was satisfac
tory.

D iscussion
In standard texts of surgery too little em
phasis is placed upon the recognition of
subphrenic abscess. Delay in the manifesta
tion of this condition caused Harley1 to
classify the condition as chronic subphrenic
abscess; he defined it as an abscess “which
has been present for six or more months
from the time of the causal condition”. H ar
ley described two patients in whom a sub
phrenic abscess had been present for 10
years.
As in our patient, the initial symptoms
are usually vague — chest pains, upper ab
dominal discomfort, occasional fever and
fatigue. Our patient’s only complaint until
a month before definitive diagnosis was that
she lacked energy. She subsequently experi
enced neck and chest pain. Vague com
plaints can lead to extensive unproductive
investigation and at best palliative treat
ment. At worst it can lead to repeated
courses of inappropriate antibiotic therapy
that may perpetuate the chronicity of the
condition. Our patient was initially treated
for pulmonary embolism.
Features in the diagnosis that are suspici
ous of an infection are generally nonspecific
— low hemoglobin, elevated leukocyte count
and erythrocyte sedimentation rate, and low
grade, intermittent, fever. In the present case
these features were present; in addition, re
sults of liver function tests were mildly ab
normal. This focused our attention on the
possibility of a subdiaphragmatic process.
The radiograph of the chest showed a slight
effusion and elevation of the diaphragm
added further support to a subdiaphragmatic
cause. When the effusion was found to be
purulent and to contain organisms more
commonly associated with intra-abdominal
sepsis, further investigations were carried
out to discover a possible focus of sub
diaphragmatic sepsis.
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Gold and Johnson5 have stated that
“combined lung-liver scintillation imaging
is a sensitive and accurate indicator of
abscesses and other abnormal collections in
the right subphrenic space”. This was cer
tainly so in our case, where the results of the
scan led to exploratory surgery.
Physical findings may be rare in cases of
subphrenic abscess. There may be little ab
normality in the chest unless the reactivation
of the abscess produces a transdiaphragmatic
inflammatory response. Such a response
must be (as in our case) of sufficient magni
tude to produce empyema or pneumonia.
The absence of an upper quadrant mass in
chronic cases is referred to by H arrison;3
whether chronic or acute, the position of the
abscess will determine the presence or ab
sence of intrathoracic involvement.
A review of the patient’s surgical and ob
stetric history is valuable and special con
sideration should be given to a history of
previous abdominal surgery. On the other
hand, 15% of subphrenic abscesses are re
ported to be without apparent antecedent
cause.6
The antimicrobial treatment of peritonitis,
whatever the cause, requires careful con
sideration. It is argued by some that the ini
tial therapy can arrest infection at the stage
of “cellulitis”.2 Aminoglycosides alone in
such cases can reduce early mortality but
result in the production of intra-abdominal
abscesses containing viable organisms.*7 This
is due in part to the polymicrobic nature of
peritonitis and the resistance of many anae
robic organisms to the aminoglycoside anti
biotics. Successful antibiotic treatment of
peritonitis must include a drug active against
the anaerobic organisms that predominate
in such cases. Currently, either chloramphe
nicol or clindamycin, usually combined with
an aminoglycoside are the drugs of choice
for systemic therapy. Nelson, Kuzman and
Cohn,8 make a strong case for intraperitoneal lavage with kanamycin after intra
operative soiling of the peritoneum.
Conclusions
The case presented draws attention to a
condition with considerable potential for
chronicity. The nonspecific complaints and
the unremarkable results of the laboratory
investigations should encourage the con-
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sideration of chronic subphrenic abscess in
any differential diagnosis. It is likely that
repeated doses of relatively ineffective anti
biotics may perpetuate the condition.
The following points should receive con
sideration for the prevention and diagnosis
of chronic subphrenic abscess.
1. Adequate antimicrobial therapy should
be instituted following surgical or traumatic
contamination of the peritoneal cavity. Sys
temic antimicrobial therapy for a period of at
least 10 days with an aminoglycoside in com
bination with either clindamycin or chloram
phenicol is recommended. In addition peri
toneal lavage with normal saline followed by
kanamycin solution may be used.
2. Following discharge from hospital,
such a patient should be reviewed for a pro
longed period of time; chronic subphrenic
abscess may develop years after surgery.
3. Special consideration should be given
to the patient with nonspecific complaints,
such as fatigue and occasional fever, whose
laboratory findings include slight leukocyto
sis and slightly elevated serum alkaline phos
phatase and aminotransferase enzyme con
centrations. These findings should arouse
strong suspicion of a chronic subdiaphragmatic abscess and prompt a careful review
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of the past surgical and obstetric history. The
patient should be investigated with a com
bined liver-lung scan, a radiograph of the
chest and a gastrointestinal series; visceral
displacement due to a mass should be speci
fically looked for on the gastrointestinal ra
diograph.
Definitive treatment of the abscess is sur
gical with antibiotics playing an adjunctive
role.
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SUBCAPITAL FRACTURE OF THE HIP: A RARE COMPLICATION OF
INTERTROCHANTERIC FRACTURE OF THE FEMUR*
GORDON A. HUNTER, MB, FRCS, FRCSfC] and ARUN MEHTA, MB, FRCS(Edin)
Three cases of subcapital fracture of the hip that
occurred after an intertrochanteric fracture of
the femur had been nailed have been described
in the literature. The tip of the nail failed to pene
trate the femoral head and a stress fracture oc
curred in two at the tip of the nail and in the
other at the tip of a blade plate. This paper re
ports three further cases of this recently recog
nized and rare complication of intertrochanteric
fractures. It is emphasized that the condition
must be recognized and treated without delay.
La litterature decrit trois cas de fracture de la
tete de la hanche qui sont survenus apres qu'une
fracture inter-trochanterienne du femur eut ete

*From the division of orthopedics, St. Michael’s
Hospital, and the University of Toronto, Toronto,
Ont.
Reprint requests to: Dr. G. A. Hunter, Ste. 202,
55 Queen St. E., Toronto, Ont. M5C 1R5.

reparee avec un clou — le bout du clou ne reussissant pas a penetrer la tete femorale et une
fracture par stress se produisant, dans deux cas,
au bout du clou, et, dans le troisieme, au bout
d'une plaque. Cette publication signale trois autres cas de cette complication rare des frac
tures inter-trochanteriennes qui n'a ete reconnue
que recemment. On souligne I’importance de savoir reconnaitre cet etat et de le traiter sans
delai.

W e report herein three cases of subcapital
fracture of the hip that occurred after an in
tertrochanteric fracture of the femur had
been nailed. Only three other cases have been
reported in the literature: Tronzo1 described
two cases in which fracture occurred at the
tip of the nail in the subcapital region of the
neck and Cameron and associates2 reported
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one in which fracture occurred at the tip of
a blade plate. Our three cases are docu
mented so that others will be made aware of
this rare complication. In addition we sug
gest possible etiologic causes and define ways
of preventing such a complication.
C ase R eports

Case I .—Three years after a right upper
lobectomy for squamous cell carcinoma of the
lung a 60-year-old man was admitted with a
trochanteric fracture of the left hip. The frac
ture was reduced and internally fixed with a
Richards screw and plate (Fig. la). Because of
the patient’s history of neoplastic disease a
biopsy of the trochanteric region was taken,
but the specimen was free of neoplastic de
posits.
The patient was readmitted 9 months later
with pain in the left hip. Radiographs suggested
a subcapital fracture of the left femur (Fig.
lb). Nine days later a total hip replacement was
performed. Two weeks after replacement sur
gery a hematoma developed; it was evacuated
and the wound debrided. Cultures of the wound
grew Pseudomonas sp. The patient was treated
with appropriate antibiotics. Wound drainage
ceased after 3 weeks but a deep infection was
suspected. At the time of writing the patient
has a dry wound; he can walk with one cane
and has an adequate range of hip movement.
His progress is being monitored carefully be
cause we suspect he may require excision
arthroplasty.
Case 2.—A 79-year-old woman was ad
mitted with an intertrochanteric fracture of
the left hip (Fig. 2a). This was treated by a
medial displacement osteotomy. Fixation was
achieved with a Thornton nail plate (Fig. 2b);
however, a revision was necessary 3 weeks la
ter at which time the fracture was immobilized
with a Richards screw and plate (Fig. 2c).
Almost 9 months later the patient com
plained of pain in the left hip. Radiographs
demonstrated a subcapital fracture. The patient
was confined to bed or chair, she had fecal and
urinary incontinence and was suffering from
senile dementia. Therefore we decided that no
further procedure was necessary or advisable.
Three years later the patient was still alive
but was unable to walk.
Fig. lb

Fig. 1.—Case 1. (a) Internal fixation with Rich
ards screw and plate of trochanteric fracture in 60year-old man. (b) Subcapital fracture 9 months
after internal fixation of trochanteric fracture.

Case 3.—A 71-year-old woman was admitted
with an intertrochanteric fracture of the right
hip (Fig. 3a). The fracture was reduced and
internally fixed with a Richards screw and
plate (Fig. 3b). Approximately 8 months later
the patient was readmitted complaining of hip
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pain. The Richards screw and plate were re
moved, but the pain persisted. Tomography 1
year after the original operation demonstrated
a subcapital fracture o f the femoral head
(Fig. 3c). The femoral head was excised and
replaced with a cemented Thompson prosthesis.
The patient recovered quickly and is doing
well.

D iscussion

In each of the two cases described by Tronzo1 of subcapital fracture following repair
of an intertrochanteric fracture, the tip of
the nail failed to pass into the femoral head.
Under these circumstances Tronzo believed
that the area just below the femoral head
is exposed to an unusual weakening process
resulting in a stress fracture at the tip of the
nail. In one case the fracture was treated
with an endoprosthesis and in the other the
fracture healed after fixation with a com
pression screw.1
Cameron and colleagues2 did not con
sider this a fatigue or stress fracture in the
usual sense. They believed that in their case
fracture occurred at a point of stress con
centration and the forces of the femoral head
were transmitted into the stiff metal nail and

Fig. 2b

Fig. 2c

Fig. 2.—Case 2. (a) Intertrochanteric fracture of left hip in 79-year-old woman, (b) Intertrochan
teric fracture after fixation with Thornton nail plate, (c) Revision of original surgery with Rich
ards screw and plate.
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then down the shaft. They called this a
“stress-riser” fracture or a “Young’s modu
lus” fracture. It is similar to fractures that
occur at the level of the last screw in a bone
plate. In view of the “stress-riser” effect,
they concluded that the internal fixation de
vice should be close to the subchondral bone
in the femoral head and that the device
should be removed as soon as possible. In
their patient the femoral head had evidently
lost its blood supply at the time of the sub
capital fracture. Therefore, they recom
mended that the fracture should be treated
by joint replacement — either unipolar with
a long-stem Thompson or Moore prosthesis
(as was done in our third patient) or with a
bipolar replacement. A long-stem femoral
component is recommended because the
screw holes in the femoral shaft left by re
moval of the blade plate act as “stress-risers”.
If the stem of the prosthesis passes distal to
these screw holes this “stress-riser” effect is
largely nullified.
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Etiology
The etiology of such fractures is specula
tive, but may be due to one or more of the
following:
1. A stress fracture, as suggested by
Tronzo.1
2. A “stress-riser” fracture, as suggested
by Cameron and colleagues.2
3. A previously unrecognized subcapital
fracture associated with an intertrochanteric
fracture.
4. The presence of soft bone (e.g., osteo
porosis or neoplastic deposits within the neck
of the femur may render the bone more
liable to fracture following introduction of
the internal fixation device and may even,
on rare occasions, be caused by the intro
duction of the device).
Prevention
In order to prevent this rare complication
of intertrochanteric fracture of the hip the
following factors should be stressed.

Fig. 3c
Fig. 3.—Case 3. (a) Intertrochanteric fracture of right hip in 71-year-old woman, (b) Repair of
intertrochanteric fracture with Richards screw and plate, (c) Subcapital fracture following removal of
internal fixation device.
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1. The femoral nail or screw should be in
serted close to the subchondral layer of the
femoral head.
2. The internal fixation device should be
removed as soon as fracture healing is sound.
3. An attempt should be made to stabilize
an unstable fracture in order to secure frac
ture healing by means of displacement osteo
tomies, the use of bone graft or even bone
cement.
4. Following removal of the internal
fixation device it may be advisable to insert
bone graft chips into the femoral neck and
head.
A dd en d u m
A fter this paper was accepted for publica
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tion, we noted a report by D. M. Baker,:f who
described three patients in whom a femoral
neck fracture developed at least 1 year after a
healed intertrochanteric fracture of the femur.
Each patient appeared to have had a second
fall. The prognosis for this second injury was
poor — one patient had nonunion of the fe
moral neck fracture and the other two required
a G irdlestone procedure.
R eferences

1. T ronzo RG: Surgery of Hip Joint, Philadel
phia, Lea & Febiger, 1973, p 526
2. C ameron HU, P ilu a r RM, H astings DE, et
al: Iatrogenic subcapital fracture of hip:
new complication of intertrochanteric frac
tures. Clin Orthop 112: 218, 1975
3. Baker DM: Fractures of femoral neck after
healed intertrochanteric fractures; com
plication of too short a nail plate. Report
of three cases. J Trauma 15: 73, 1975

RADIOLUCENT URINARY CALCULUS IN A TRANSPLANT PATIENT:
AN UNSUSPECTED CAUSE OF URETEROPELVIC OBSTRUCTION*
MARTIN G. McLOUGHLIN, MD
The occurrence of nephrolithiasis and nephrocalcinosis in the patient who has undergone a
renal transplant is rare and is usually related to
parathyroid hypersecretion. A case is presented
in which the patient had a radiolucent stone that
arose as a result of the use of nonabsorbable
sutures. It is clear that nonabsorbable sutures
should be avoided in renal allotransplant reci
pients.
L'apparstion d'une nephrolithiase et d’une nephrocalcinose chez le patient qui a subit une
greffe renale est un evenement rare qui est habituellement relie a une hypersecretion de la parathyroide. On presente un cas ou le patient etait
porteur d'un calcul translucide aux rayons-x dont
la formation est due a I'emploi de sutures non
absorbables. II est clair qu'on devrait eviter ('uti
lisation des sutures non absorbables chez les
receveurs d'allogreffes renales.

T h e recipient of renal transplant who has
a functioning graft has the ability to pro
duce the active form of vitamin D (1, 25dihydroxycholecalciferol) resulting in a fair
ly stable state of calcium metabolism. Rare*From the department of urology, Brady Urolo
gical Institute, Johns Hopkins Hospital, Baltimore,
MD.
Reprint requests to: Dr. M. G. McLoughlin, De
partment of urology, Johns Hopkins Hospital, Bal
timore, MD 21205.

ly does hyperparathyroidism result in hyper
calcemia, hypercalcuria and nephrocalcinosis or urinary calculi. Obstruction of the
ureteropelvic junction developed at the
anastomotic site of ureteral pyelostomy in
our patient 3 years after renal allotrans
plantation. At operation we found a radio
lucent stone that contributed to the obstruc
tion.
C ase R epo rt
Chronic renal failure secondary to chronic
glomerulonephritis developed in a 56-year-old
man; a kidney donated by his brother was
placed in the left renal fossa. Because of a short
ureter, the preferred ureteral neocystotomy
could not be done; instead the patient’s ureter
was anastomosed to the donor pelvis with a
running 6-0 polypropylene (Prolene) suture.
Five days after transplantation the patient
underwent reoperation for a large pyelocutaneous fistula; this was closed with running 6-0
Prolene suture. Postoperatively he did well
and was discharged 7 days after the second
operation.
The patient was admitted to hospital 3 years
later with hematuria, mild hypertension (dias
tolic pressure, 100 mm Hg) a serum creati
nine concentration of 1.5 m g/dl, a serum cal
cium concentration of 8.7 m g/dl and a uric
acid concentration of 7.6 m g/dl. A radiograph
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of the abdomen showed no calcification in
the area of the renal graft or ureter (Fig. 1).
Intravenous urography showed obstruction at
the ureteropelvic junction (Fig. 2) and retro
grade pyelography confirmed the obstruction.
At operation, the ureter was traced up to the
ureteropelvic junction, which was encased in
dense scar tissue; a stone (diameter, 1 cm) was
found at the ureteropelvic junction attached to
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the Prolene suture. The stone was removed;
on analysis it contained oxalate, phosphate and
a small quantity of calcium. A no. 8 feeding
tube was placed down the ureter and into the
patient’s bladder; this was used as an internal
stent. Any attempt to close the pyelotomy
would have resulted in stenosis; we were not
able to mobilize tissues to perform a YV
plasty. Therefore, an incision was made in the
kidney capsule and a rotational capsule flap
was formed, suturing the capsule over the
pyelotomy with interrupted 4-0 Dexon sutures.
Postoperatively ileus developed; on the 7th
day after operation the patient suffered a
subendocardial myocardial infarction. Fortun
ately his recovery was uneventful. On the 14th
postoperative day the internal stent was re
moved; intravenous pyelography showed no de
lay in function (Fig. 3). The serum creatinine
concentration was 1.0 mg/dl. The patient is
no longer hypertensive and has been dis
charged from hospital.
D iscussion
Reports in the literature on nephroli
thiasis and nephrocalcinosis in transplant
recipients emphasize that most urinary cal
culi are related to parathyroid abnormali
ties.-'4 Steroid administration can result in
increased phosphorus excretion with second
ary hypercalcemia, and the production by
the functioning graft of 1, 25-dihydroxycholecalciferol can increase calcium absorp
tion from the intestine; however, these

Fig. 2.—Intravenous urogram demonstrating
obstruction at ureteropelvic junction in renal
allograft.

Fig. 3.—Intravenous pyelogram 2 weeks after
operation demonstrates good function and pat
ent ureteropelvic junction.
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factors usually do not result in the produc
tion of hypercalcemia and hypercalcuria. In
our case the ureteropelvic junction was
stenotic and a urinary calculus was attached
to a Prolene suture. The calcium determina
tions in this patient were within normal
limits, suggesting that the stone was formed
as a direct result of the use of Prolene. We
used Prolene in difficult urologic procedures
because our experience with absorbable
sutures had been unsatisfactory and because
we were able to repair many urologic com
plications with Prolene.r> Thus, it may be
that while we resolved one complication,
we laid the groundwork for secondary com
plications, because prolonged exposure of
the nonabsorbable Prolene suture to urine
resulted in stone formation. For this reason,
we now use polyglycolic acid sutures in re
constructive urologic procedures involving
renal allotransplant recipients. In the present
case, after opening the stenotic ureteropelvic
junction and removing the calculus, the large
defect was reconstructed by use of a renal
capsular flap; this maneuver provided ade
quate drainage with a leak-proof closure.
Nonabsorbable suture material utilized in
reconstructive ureteropelvic surgery may
provide a nidus for stone formation in the
immunosuppressed patient. The stone in our
patient was radiolucent; at operation it was
found to be the unsuspected cause of an
obstructive uropathy. It is important that
this clinical entity be recognized as a possibi
lity in preoperative planning for the treat
ment of obstruction at the ureteropelvic
junction in renal allotransplant recipients.
R eferences
1. A lfrey AC, J enkins D , G roth CG, et al:
Resolution of hyperparathyroidism, renal
osteodystrophy and metastatic calcification
after renal homotransplantation. New Engl
J M ed 279: 1349, 1968
2. L eapman SB, V idne BA, Butt KM, et al:
Nephrolithiasis and nephrocalcinosis after
renal transplantation: case report and re
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cations in renal allotransplant recipients.
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CORRESPONDENCE
GASTROINTESTINAL HORMONES
To the editor: The study of gastrointestinal
hormones is a rapidly advancing field that
has generated much interest. Because of the
speed at which advances are being made it
seems that a number of points outlined in a
recent review article by S. N. Sullivan on
gastrointestinal hormones in this journal
(19:295, July 1976) require clarification.
The Author states that the APUD cells
found in the pituitary gland, thyroid gland,
adrenal gland, pancreas, lungs and gastroin
testinal tract are believed to be of neuroecto
dermal origin. There is evidence that the C
cells in the thyroid do migrate from the neu
ral crest; however, two studies1- - have pro
vided evidence that the cells of the pancreas
and gastrointestinal tract do not originate
from the neural crest. These studies stress
that the APUD characteristics are not suffi
cient criteria to substantiate the neural crest
origin of these cells.
Gastrin is synthesized in antral and duo
denal G cells. The adult human antral muco
sa contains 10 times more immunoreactive
gastrin (IRG) than the duodenal mucosa; the
adult pancreas contains no IRG. However,
IRG has been found in the pancreatic glands
of the human, rat and calf fetus. The pan
creatic a j cell does not contain gastrin. The
pancreatic D cell has been shown to contain
somatostatin.
Four major components of gastrin have
been identified in serum and tissue extracts.
Mini-gastrin, the smallest of these compo
nents, has recently been found to contain 14
instead of the originally described 13 amino
acids; therefore, it is referred to in the
Walsh nomenclature as G-14. Recent experi
ments in man have shown that natural hu
man G-17 has a half life of 6 to 7 minutes
while natural human G-34 has a half life of
40 to 45 minutes. With the information
available, it is difficult to make a case for
gastrin as a major determinant of normal
lower esophageal sphincter pressure.
Regarding the Zollinger-Ellison syn
drome, a recent review article, not cited by
Sullivan,3 relates clinical aspects with bio
chemical and morphologic characteristics of
gastrinoma tissue. Two entries in Sullivan’s
Table VIII are incorrect: some Zollinger-
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Ellison patients release gastrin after food and
neither condition affects the pancreatic D
cells, the somatostatin-producing cells. The
incidence of hypergastrinemia resulting from
G-cell hyperplasia is extremely rare. The sur
gical procedure of choice in the ZollingerEllison syndrome is total gastrectomy, main
ly because it has the best prognosis, since all
gastrinomas seem to express their malignant
potential through excess acid production.
In the section on enteroglucagon (gluca
gon-like immunoreactivity [GLI]) Sullivan
creates the impression that there is only one
substance. Recently the Novo group4 isolated
one GLI that contains 100 amino acids. This
partially characterized GLI protein contains
the 29-amino-acid glucagon sequence as a
part of its carboxyl portion. The Novo group
is precise in pointing out that this is one of
probably a number of different GLI mole
cules.
The WDHA or Verner-Morrison syn
drome is probably a collection of a number
of different diarrheal states. It has been sug
gested that hormonal factors are involved in
the etiology of these syndromes. Claims have
been made for secretin, gastric inhibitory po
lypeptide, vasoactive intestinal peptide and
human pancreatic polypeptide as the etiologic factor. To date, none of these claims
have been substantiated. A more tenable ap
proach is that the combined activities of a
number of hormones cause this syndrome.
This approach is supported by the relative
high frequency of multihormonal pancreatic
endocrine tumours.
A number of the conclusions drawn in the
review article are premature. A thorough
examination of the data available about the
physiologic and pathophysiologic roles of
different gastrointestinal hormones leads to
the conclusion that we are only beginning to
realize the problems involved in the accurate
estimation and eventual interpretation of re
sults regarding these different hormones.
N. S. T rack,

ph d

Department of surgery,
McMaster University,
Hamilton, Ont.
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To the editor-. In reply to Dr. Track’s com
ments: for those who attempt to review a
topic there is often an unsettling aspect to
the “information explosion” — yesterday’s
fancy may be today’s fact, while today’s fact
may be tomorrow’s fiction. When I dotted
the last “i” and crossed the last “t” in my re
view of gastrointestinal hormones it was as
accurate as I could make it, but in the last
analysis it is only my interpretation of the
data that I had available.
Most of Dr. Track’s comments are valid,
although 1 know more authoritative voices
than mine would give him arguments on sev
eral points. It is obvious that he has digested
the meat of the matter and I am pleased to
see that he did not miss the flavour. I can
only reiterate the final statement in my pa
per: “Much is still to be discovered.”
5. N. Sullivan ,

md

Royal Postgraduate Medical School,
University of London,
London, England.

CRITIQUE OF ITEM 350 (SESAP II)
Bradycardia can produce the symptoms ob
served in Stokes-Adams attacks, in angina
pectoris, or in association with congestive heart
failure. Pacemakers have proven effective in
controlling ventricular bradycardia. The use of
a pacemaker should be considered for the in
dividual who develops a complete heart block
prior to an operation, because intrinsic brady
cardia can interfere with cardiac response to
hemodynamic changes imposed by a general
anesthetic and operative manipulations. Of the
choices presented, atrial fibrillation is the least
likely indication for use of a temporary or per
manent pacemaker.
Q
R eference

350/1. Chardack WM: Cardiac pacemaker,
in Sabiston DC Jr (ed): (Davis-Christopher)
Textbook of Sugery, ed 10. Philadelphia, WB
Saunders Co, 1972, pp 2079-2099

when shock
threatens the lung
helps reduce pulmonary
damage and increase ^
survival rates.

• preserves lysosome and cell membranes, thereby preventing the release o f destructive
lysosomal enzymes3
• preserves platelets thereby reducing the risk o f intravascular coagulation'
• preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery o f patients in shock is often com plicated by a pattern o f deteriorating pul
monary function, com m only described as shock lung. This pulmonary insufficiency
progresses despite restoration of haemodynamic balance and apparent stabilization o f
the acute episode.
Cinder conditions o f prolonged shock, lack o f oxygen at the cellular level causes
alterations in the oxygen-carbon dioxide exchange mechanism. T h ese
changes in cell metabolism lead ultimately to interstitial oedema and peri■
w
vascular haemorrhage.1 Polymorphonuclear leukocytes aggregate in
the pulmonary capillaries and obstruct the pulmonary vascular
bed. As these trapped cells break down, they release lysosomes, tiny subcellular particles containing proteolytic
enzymes.’ These enzymes attack their host cell and
go on to dam age or destroy other cells.2 The rem
suiting tissue damage may not readily repair
itself even if the shock patient survives.
When administered in conjunction with
standard therapeutic measures, SoluMedrol exerts a protective effect
jj*
on the lung and improves the
patient’s chance o f survival.
Prescribing information on page 180
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REVIEWS

POSTOPERATIVE CONGENITAL HEART
DISEASE. Edited by Ammon Rosenthal,
Edmund H. Sonnenblick and Michael Lesch.
166 pp. Illust. Grune & Stratton, Inc., New
York; Longman Canada Limited, Toronto,
1975. $16.75.

This book is a collection of review articles,
mainly by clinicians, on the long-term post
operative course of patients with congenital
heart disease. The papers included were ori
ginally published during 1975 in “Progress in
Cardiovascular Diseases”. Taken as a whole
this book is a complete discussion of the post
operative clinical, radiologic and electrocardio
graphic aspects of the most common congenital
cardiovascular disorders; postoperative residua,
sequelae and complications are well presented.
Modern noninvasive techniques for patient
assessment, such as vectorcardiography, ultra
sound, radionuclide angiocardiography and ear
oximetry are covered. Of particular interest is
the chapter describing the experience with
prosthetic valve replacement in children and
the chapter on postsurgical myocardial per
formance; we are reminded that despite suc
cessful correction of the anatomic lesion, the
pump function of the heart may remain sub
normal.
This book will be useful to the pediatric
cardiologist, the cardiovascular surgeon and
the cardiologist whose practice includes adults
who, as children, underwent repair of con
genital heart defects.
O.

H.

T

e l x e ir a

Section of cardiology,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.

PROGRESS IN CARDIOLOGY 4. Edited by
Paul N. Yu and John F. Goodwin, 224 pp.
Illust. Lea & Febiger, Philadelphia; The
Macmillan Company of Canada Limited,
Toronto, 1975. $16.65.

This slim volume is the fourth in an annual
series; the authors have selected specific topics
in cardiac function and disease for an in-depth
analysis and explanation.
Some chapters, such as those dealing with
mitral valve prolapse, quantitative left ventri
culography and the preservation of myocardium
summarize present knowledge on topics of
current interest. Others, particularly the chap
ters on the genesis of the heart sounds and the
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ever-present problem of digitalis toxicity pres
ent new experimental data and hypotheses,
which supplement and sometimes challenge
traditional concepts. In addition some chapters
explore exotic topics such as coronary artery
disease in children and high-altitude pulmonary
edema.
One of the best contributions is a thorough
review of the source, assay methods and
clinical significance of enzymes implicated in
myocardial disease; infarct quantification
through measurement of enzyme release is also
described.
This book is neither for skimming briefly
nor for uninterrupted reading; the digestion of
a single chapter will give the reader a thorough,
though not always balanced, topic survey and
the references are up to date and useful.
I think this book would be of interest to
cardiologists, cardiac surgeons and internists;
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the discussion should concentrate on preven
tion of complications. Specific points in the
preoperative assessment and operative tech
nique should be made; these could have been
followed up with a description of the methods
available for dealing with complications. This
format was followed in many of the chapters
with great success; unfortunately, in other
chapters the conditions were discussed as if
the book was a general text on urology.
The book is recommended to residents in
training, but practising urologists will also
profit from it, for the book includes some new
and useful practical points regarding the man
agement of uncommon urologic problems.
S. A. A wad

Department of urology,
Queen’s University,
Kingston, Ont.

B. C. T horton
Division of cardiology,
Ottawa Civic Hospital,
Ottawa, Ont.

COMPLICATIONS OF UROLOGIC SUR
GERY. PREVENTION AND MANAGE
MENT. Edited by Robert U. Smith and
Donald G. Skinner. 520 pp. Illust. W. B.
Saunders Company, Philadelphia; W. B.
Saunders Company Canada Limited. Tor
onto, 1976. $30.40.

This book is made up of 24 chapters by 26
authors, and includes discussions on the com
plications of urologic surgery and urologic
trauma. The editors should be complimented
for their choice of authors. The reader will
sense that the information presented stems
from personal experience; this is particularly
valuable in discussing uncommon conditions,
where special expertise is necessary. The book
deals largely with the surgical aspects of uro
logy; however, chapters are included on those
medical complications especially relevant to
urologic practice.
Although the prevention and treatment of
complications are included in most standard
text books, it is useful to have this information
thoroughly discussed. Unfortunately, some of
the authors did not focus on the objectives of
the book. It is true that the technical details of
urologic surgery are important in avoiding
complications but detailed descriptions of
operative techniques are inappropriate. In a
book such as this, the reader would have ex
pected to see the complications clearly listed;

RECENT ADVANCES IN UROLOGY. No.
2. Edited by W. F. Hendry, 353 pp. Illust.
Churchill Livingstone, Edinburgh; Longman
Canada Limited, Toronto, 1976. $39.50.

All who set out to prepare a book on recent
advances must choose between detailed dis
cussions of a few topics or a shorter discussion
of many; Hendry has chosen the latter. Four
teen topics are reviewed; these include urinary
tract infection, renal replacement therapy, ure
throplasty, and carcinoma of the urothelium,
prostate and testis.
The bibliography as far as it goes is excel
lent. Unfortunately most references are to
works published before 1975 and therefore can
hardly be considered “recent”; for example,
the paper on renal replacement therapy, a ra
pidly advancing field, includes only 3 references
from 1975; the other 67 references are of an
earlier vintage.
The contributors to this book include such
well-known British urologists as Blandy, Turner-Warwick and Innes Williams. The editor
expresses in the preface his hope that “the
trainee surgeon will find this book useful in
studying for higher examination” and that “the
practising surgeon will find something of in
terest”. I am sure that one could not pass any
“higher examination” by studying this book
alone, though it does survey important topics;
it is brief and easily read and is useful as a
quick review for the busy practising urologist.
T. J uda

Ste. 304,
25 Brunswick Ave.,
Toronto, Ont.
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CANADIAN ASSOCIATION
OF GENERAL SURGEONS/
L’ASSOCIATION CANADIENNE DES
CHIRURGIENS GENERAUX
The inaugural meeting of the Canadian
Association of General Surgeons/L’Asso
ciation Canadienne des Chirurgiens Generaux will be held at the Royal York Hotel,
Toronto, on Wednesday, May 11 and
Thursday, May 12, 1977.
All certificants in general surgery of the
Royal College of Physicians and Surgeons
of Canada, or of the Corporation Professionelle des Medecins du Quebec, are in
vited to attend, and to stay for the “Gallie
Day” surgical program on Friday, May 13,
sponsored by the University of Toronto.
The program will include symposia and
panels on peptic ulcer disease, cancer of
colon and rectum, pancreatitis, intensive
care, recent advances in continent ileostomy,
retained common duct stones, hemorrhoids,
immunotherapy, and evaluation of blood
flow.
Translation services will be provided.
Registration fee for the meeting is $50.
Banquet tickets are $15. per person.
For program and registration form, please
write to: Canadian Association of General
Surgeons, Room 310, Banting Institute, 100
College St., Toronto, Ont. M5G 1L5.

